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ABSTRACT 
SYNTHETIC APPROACHES TO THE UNDERSTANDING OF DNA 






 DNA methylation is a major source of genetic variation and cancer. Methylation occurs 
when nucleophilic DNA bases react with methylating agent methyl methanesulfonate 
(MMS), dimethyl sulfate (DMS), N-methyl-N-nitrosourea (MNU), N-methyl-N′-nitro-N-
nitrosoguanidine (MNNG), etc. N7-methyl-2ʹ-deoxyguanosine (N7-methyl-dG, or 
7Me
dG) 
adduct is the most abundant DNA methylation products for most methylating agents. 
DNA polymerase actions on 
7Me
dG are difficult to study due to its instability against ring-
opening hydrolysis and deglycosylation. Oligonucleotides containing a single chemical 
adduct of 
7Me
dG cannot be chemically synthesized. In addition, 
7Me
dG is unstable in vivo 
due to the presence of DNA repair enzymes. This work explores the possibility of using 
stable analogues of N7-methyl-dG to study the polymerase bypass. The chemical 
synthesis of N7-methyl-9-deaza-dG (
7Me9C
dG) has been developed and the nucleoside has 
been successfully incorporated into oligonucleotides. Thermal melting studies show that 
replacement of dG by 
7Me9C
dG only slightly decreases DNA duplex stability. Replication 
of the DNA templates containing 
7Me9C





dG) by Klenow fragment of E. coli DNA polymerase I is examined. 






dG templates are 
comparable to the dG template, although the 7-methyl group slows down the turnover 





against the actions of formamidopyrimidine DNA N-glycosylase (Fpg) and human 
 
 
alkyladenine DNA Glycosylase (hAAG) are also studied.
 7Me9C
dG is stable in the 




dG is cleaved by Fpg, and possibly by hAAG 
but in an extremely slow rate. This work demonstrates that 
7Me9C
dG is a better analogue 
than 
7Me7C
dG for future cellular studies. 
           Epigenetic mechanisms regulate the expression of genetic information. A major 
epigenetic event is DNA cytosine methylation, which is catalyzed by the DNA 
methyltransferases (DNMTs). Among different mammalian DNMTs, DNMT1 is the 
most abundant and active, and plays multiple roles in carcinogenesis, embryonic 
development, and several other biological functions. Reactivation of silenced tumor 
suppressor genes by DNMT inhibitors (DNMTi) is provides a relatively new approach to 
cancer therapy. A couple of irreversible nucleoside DNMT inhibitors have been 
developed clinically. However, due to their low specificity and high cellular toxicity, 
there is a clear need for the development of reversible inhibitors. S-adenosyl 
homocysteine (SAH) is a known strong inhibitor of DNA methyltransferases. Based on 
the crystal structure of SAH bound to human DNMT1-DNA complex, a series of 
transition state analogues have been designed to occupy the SAH binding site and the 
cytosine binding site simultaneously. These analogues have been successfully 
synthesized from adenosine using a modular approach. Inhibition of DNMT1 by these 








SYNTHETIC APPROACHES TO THE UNDERSTANDING OF DNA 

































A Dissertation   
Submitted to the Faculty of 
New Jersey Institute of Technology  
in Partial Fulfillment of the Requirements for the Degree of 
Doctor of Philosophy in Chemistry 
 
























Copyright © 2015 by Jagruti Rana 
 
ALL RIGHTS RESERVED 
.
APPROVAL PAGE 









Dr. Haidong Huang, Dissertation Advisor                Date 





Dr. Somenath Mitra, Committee Member      Date 





Dr. Edgardo Farinas, Committee Member      Date 





Dr. Tamara Gund, Committee Member      Date 





Dr. Pradyot Patnaik, Committee Member      Date 





Degree:	 Doctor of Philosophy
Date: 	January 2015
Undergraduate and Graduate Education:
• Doctor of Philosophy in Chemistry
New Jersey Institute of Technology, Newark, NJ, 2015
• Bachelor of Education,
South Gujarat U niversity,Guj arat, India, 2006
• Master of Science in Chemistry,
South Gujarat University,Gujarat, India, 2004
• Bachelor of Science in Chemistry,
South Gujarat University, Gujarat, India, 2002
Major: 	Chemistry
Publications:
Rana, J., and Huang, H. (2013) Actions of the Klenow fragment of DNA polymerase I
and Some DNA Glycosylases on Chemically Stable Analogues of N7-methyl- 2′ -
deoxyguanosi ne, Bioorganic & Medicinal Chemistry 21 , 6886-6892.
Patel, S., Rana, J., Roy, J., and Huang, H. (2012) Cleavage of Pyrene-Stabilized RNA
Bulge Loops by Trans-(+/-)-cyclohexane-1,2-diamine, Chemistry Central Journal
6, 3.
Presentations:
Rana, J., and Huang, H. (April 2014) Chemically Stable Analogues of 7-Methyl-2’ -
Deoxyguanosine: Synthesis, Polymerase Replication, and Thermal Stability
Studies , 59th Annual NJ Academy of Science Meeting, Raritan Valley





Rana, J., and Huang, H. (February 2014) Chemically Stable Analogues of 7-Methyl-2’-
Deoxyguanosine: Synthesis, Polymerase Replication, and Thermal Stability 
Studies,  Female Research Showcase  hosted by  Society of Women Engineers, 
New Jersey Institute of Technology, Newark, NJ. 
 
Rana, J., Gao, X., and Huang, H. (November 2013) Polymerase Bypass of Chemically 
Stable Analogues of N7-Alkylguanine, the Most  Abundant DNA Alkylation 
Damage Products, 9th Annual Graduate Student Research Day, New Jersey 
Institute of Technology, Newark,NJ. 
 
Rana, J., and Huang, H. (June 2013) Chemically Stable Analogues of 7-Methyl-2’-
Deoxyguanosine:  Synthesis, Polymerase Replication, and Stability against 
Deglycosylation Action of Base-Excision-Repair Enzymes, The Chemical 
Biology Discussion Group Year-End Symposium, The New York Academy of 
sciences (NYAS), New York. 
 
Rana, J., and Huang, H. (November 2012) Chemically Stable Analogues of 7-Methyl-2’-
Deoxyguanosine : Synthesis, Polymerase Replication and Thermal Stability 
Studies, 8th Annual Graduate Student Research Day, New Jersey Institute of 
Technology, Newark,NJ. 
 
Rana, J., Roy, J., Patel, M., and Huang, H. ( April 2012) Rational Design of DNA 
Aptamer Sensors for Adenosine and 8-Oxoguanine, 57th Annual NJ Academy of 
Science, Meeting, Seton Hall University, South Orange, NJ. 
 
Rana, J., Roy, J., Patel, M., and Huang, H. ( March 2012) Rational Design of DNA 
Aptamer Sensors for Adenosine and 8-Oxoguanine., 243rd ACS National 





























This kept me going: 
 
They all attain perfection when they find joy in their work. 
In Hindi: जब                     ज        ब                      
- Shrimad Bhagavad Gita 
 
 
To my loving husband, Snehal 
For his love, support, invaluable patience, and 
 encouragement throughout the process of my studies.  
THANK YOU. You believed in me even when I did not believe in myself. 
 
To my loving parents: Dhansukhbhai and Urmilaben  
For their unconditional love and support. 
 Thanks for being a constant motivational source to me. 
 
To my sweet sisters: Manisha, Hetal 
For supporting me and encouraging me with their best wishes. 
 
To my caring brother-in-law, Mayank 
For standing up by our family through the good times and bad. 
 
To my loving parents-in-law: Ishverbhai and Kusumben 
For supporting me and being patient. 
 
To my beautiful daughter, Prisha 
For being my little cheerleader. 
We did it! 
 
 









A major research project like this is never the work of anyone alone. The contributions of 
many different people, in their different ways, have made this possible. I would like to 
extend my appreciation especially to the following.  
This thesis would not have been possible without the invaluable guidance and 
support of my advisor Dr. Haidong Huang. I offer my sincerest gratitude to him for his 
patience, motivation, enthusiasm, and immense knowledge as well as his pain-staking 
effort in proof reading the drafts, are greatly appreciated. I could not have imagined 
having a better advisor and friendlier mentor for my doctoral study. I am also very 
grateful to Dr. Somenath Mitra, Dr. Edgardo Farinas, Dr. Tamara Gund and Dr. Pradyot 
Patnaik for their contributions as members of my dissertation committee and providing 
insightful comments. 
My sincere thanks also go to Dr. Venanzi Carol for her valuable support as an 
academic advisor. My sincere thanks go to Prof. Willis B Hammond for allowing me to 
use Hydrogentaion apparatus in his lab. One more time I would like to thank Dr. Tamara 
Gund for allowing me to use her lab during course of my study. 
 I am also thankful to Ms. Clarisa Gonzalez-Lenahan, Associate Director of 
graduate studies, for her invaluable help in the thesis review. 
My appreciation also goes to the Department of Chemistry and Environmental 
Science for offering me Teaching Assistantship. Additionally, I would like to give thanks 
Dr. Chaudhery Hussain, Dr. Pin Gu, Yogesh Gandhi, the Late Gayle Katz, Genti Price for 




during my teaching assistantship at NJIT. I am grateful for the financial, academic and 
technical support from New Jersey Institute of Technology.  
Last, but by no means least I would thank my fellow labmates  Peter, Xun and 
Rui, also my past labmates  Shanshan, Jyoti, Rajni, Mayur, Meng and other lab members 
for their continual support and encouragement throughout my study. I owe a lot to my 
friends: Kajal, Megha, Jalpa, Hemant,Tripura for their help and emotional support. 
Finally, I would especially like to thank my beloved husband if it weren’t for his 
continued love and support, I’m not so sure that I wouldn’t be where I am today. Finally, 
thanks to my grandma, the Late Gajaraben Rana who taught me the important lessons of 
life, Sarojmashi, my babysitter Meenaben, my nieces, nephews, all my friends and family 
members for their undying love and support. 
Thank God for the wisdom and perseverance that he has been bestowed upon me 
during this research project, and indeed, throughout my life: "I can do everything through 




TABLE OF CONTENTS 
 
Chapter Page 
1 GENERAL INTRODUCTION………………………………………………. 1 
 1.1 DNA Damage and Mutation……………………………………………. 1 
 1.2 DNA Methylation………………………………………………………. 5 
 1.3 DNA Methylation and Epigenetics…………………………………….. 8 
 1.4 DNA Methylation and Cancer………………………………………….. 11 




 2.1 Introduction……………………………………………………………. 15 
  2.1.1  Biological Significance of N-Methyl and O-Methyl Adducts… 17 
 2.2 Need for Stable Analogues of N7-Methyl-Guanine……………………. 21 
 2.3 Design of the Analogue of N7-Methyl-Guanine………………………. 23 
 2.4 Synthesis of 
7Me9C
dG Phosphoramidite and Oligonucleotides………….. 25 
  2.4.1 Materials and Methods…………………………………………. 33 
 2.5 Thermal Stability of Duplex DNA Containing N7-Methyl-9- deaza-dG 40 
  2.5.1 UV Melting Temperatures……………………………………… 40 
  2.5.2 Results and Discussion…………………………………………. 41 
3 REPLICATION OF N7-METHYL-9-DEAZA-DG AND 7-METHYL-7-  
DEAZA-dG BY KLENOW FRAGMENT (EXO
-













TABLE OF CONTENTS 
(Continued) 
 
Chapter     Page 
 3.1 Background Information……………………………………………… 44 
  3.1.1 Mechanism of DNA Polymerization and Methods in the 
Measurement of DNA Polymerization Efficiency and 
Fidelity ……………………………………………………….  
48 
 3.2 Experimental………………………………………………….............. 53 
 3.3 Results and Discussion of Polymerase Assays……………………….. 54 
 3.4 Conclusion………………………………………………………......... 58 
4 STABILITIES OF THE GLYCOSIDIC BONDS OF N7-METHYL-9- 




 4.1 Background Information……………………………………………… 60 
 4.2 Experimental………………………………………………….............. 63 
 4.3 Results and Discussion of Glycosylase Assays………………………. 64 
 4.4 BER Repair Inhibition Assay for Inosine in the Presence of 
7Me9C
dG 67 
 4.5 Conclusion……………………………………………………………. 68 




 5.1 Introduction…………………………………………………………… 70 
  5.1.1 DNA Methylation…………………………………………… 70 










  5.1.3 Biological Importance of DNA Methylatransferase (DNMT) 72 
 5.2 Developed DNMT Inhibitors…………………………………………. 73 
 5.3 Crystal Structure Study and Design Concept for DNMTi……………. 78 
 5.4 Synthesis of DNMT Inhibitors……………………………………….. 82 
  5.4.1 Retrosynthetic Analysis……………………………………… 82 
  5.4.2 Synthesis of the Common Precursor 31…………………….. 84 
  5.4.3 Synthesis of 2-(o-Benzyloxy)phenylacetaldehyde(33)……… 86 
  5.4.4 Synthesis of Compound 25………………………………….. 87 
  5.4.5 Synthesis of 4-Nitrophenylacetaldehyde (34)……………….. 91 
  5.4.6 Synthesis of Compound 26………………………………….. 94 
 5.5 Materials and Methods……………………………………………… 100 
  5.5.1 Organic Synthesis……………………………………………. 100 
 5.6 Conclusions and Future Studies……………………………………… 107 
APPENDIX …………………………………………………………………….. 108 
 A.1 
1
H NMR Spectra…………………………………………………….. 108 
 A.2 
13
C NMR Spectra……………………………………………………. 131 










LIST OF TABLES 
 
Table Page 
2.1 Factors that Affected the Synthesis of 7-Methyl-9-deaza-dG…………………… 29 
2.2 Thermodynamics of the Formation of Duplex DNA Containing 
7M9C
dG………..
   
 43 












   
   
   
   
   
   
   
   
   
   
   
   
   
   
   





LIST OF FIGURES 
 
Figure Page 
1.1 DNA base pairing (G with C and A with T), and the major and minor grooves 
 
2 
1.2 Structure of DNA base lesions…………………………………………………. 4 
1.3 Methylation patterns of the DNA bases…………………………………………    
 
6 
1.4 Methylation pattern in genomic DNA………………………………………...... 12 
1.5 Members of mammalian DNMTs family………………………………………... 13 
2.1 Formation of N7-Methyl-dG (
7Me
dG) adduct from nnk………………………. 16 
2.2 Hydrolysis pathways of N7-alkyl-dG…………………………………………… 19 
2.3 Structures of DNA methylation lesions………………………………………… 20 
2.4 N7-Methyl-dG Analogues……………………………………………………….. 24 
3.1 Cartoon depiction of DNA Polymerase Structure………………………………. 45 
3.2 Cartoon depiction of DNA Polymerase Processivity…………………………… 46 
3.3 Kinetic mechanisms for most DNA Polymerases……………………………….. 49 
3.4 Polymerase assays……………………………………………………………… 53 
3.5 A Crystal structure of Kf (exo
-




4.1 Two pathways for base excision repair of damaged bases in human DNA…. 62 




4.3 Incubation of duplex DNA 23 with NaOH……………………………………… 67 








4.4 Inhibition of hAAG on a dI substrate by duplex DNA containing 
7Me9C
dG.  68 
5.1 Methylation of cytosine catalyzed by DNMTs………………………………… 70 
5.2 The proposed mechanism of DNA Cytosine-C5 methylation………………… 72 
5.3 Nucleoside DNMTi……………………………………………………………... 74 
5.4 The mechanism of 5-azanucleoside analogues induced degradation of DNMTs. 
 
75 
5.5 Chemical structures of non nucleoside DNMT inhibitors and other selected 
compounds with proposed demethylating activity…………………………….. 
 
77 
5.6 Interactions between SAH mDNMT1-DNA complex…………………………. 79 




5.8 The flipped out cytosine is stabilized by surrounding residues in the active site 
of the enzyme…………………………………………………………………… 
 
80 
5.9 Design of a transition state inhibitor of DNMT……………………………… 81 
5.10a Mass Spectra of Compound 36…………………………………………………. 89 
5.10b Mass Spectra of Final Compound………………………………………………. 90 




H NMR Spectrum of 4-Nitrobenzaldehyde…………………………………….        93 
   
   
   









2.1 Reported Synthesis of the Nucleobase 
9C
G……………………………………. 26 





2.3 Synthesis of Protected Methyl Glycoside of 2’-deoxyribose…………………… 28 
2.4 Synthesis of 
7Me9C
dG Nucleoside………………………………………………. 30 
2.5 Synthesis of 
7Me9C
dG Phosphoramidite………………………………………… 31 
5.1 Retrosynthetic Analysis of Target Compound………………………………….. 82 
5.2 General Synthesis Route………………………………………………………... 83 
5.3 Synthesis of Compound 31……………………………………………………… 85 
5.4 Reductive Amination of Compound 30…………………………………………. 86 
5.5 Synthesis of 2-(o-Benzyloxy)phenylacetaldehyde (33)………………………… 87 
5.6 Synthesis of Methyl Ester Compound 36……………………………………….. 88 
5.7 Synthesis of Compound 25……………………………………………………… 88 
5.8 Synthesis of Compound 4-Nitrophenylacetaldehyde (34)……………………… 92 
5.9 Synthesis for Ethyl 4-oxobutanoate…………………………………………….. 95 
5.10 Modified Synthesis of Compound 31a (by Reductive Amination)…………… 96 
5.11 Reductive Amination of Compound 30 and Compound 34…………………… 97 
5.12 Synthesis of Compound 31a (by N-Alkylation)………………………………… 98 
5.13 Synthesis of Compound 26……………………………………………………… 99 








DNA Deoxyribonucleic acid 
7C
dG 7-deaza-2’-deoxyguanosine 
DNMT DNA methyltransferase 
MMS Methyl methanesulfonate 
DMS Dimethyl sulfate 




O6-Me-G O6-methylguanine  
SAM S-adenosylmethionine 
DNMT DNA methyltransferase  
7Me9C
dG N7-methyl-9-deaza-dG  
7Me7C
dG 7-methyl-7-deaza-dG 
DMF N, N-dimethylformamide (Solvent) 
dmf N, N-dimethylformamide (Protecting group) 
DBU Diazabicyclo[5.4.0]undec-7-ene  
DCM Dichloromethane 
MMS Methyl methanesulfonate  










MNU N-methyl-N-nitrosourea  
MNNG N-methyl-N′-nitro-N-nitrosoguanidine  
Fpg formamidopyrimidine DNA N-glycosylase  
hAAG human alkyladenine DNA Glycosylase  
SAH S-adenosyl homocysteine 
DNMTi DNMT inhibitors  
MeC 5-methylcytosine  
AP Apurinic or abasic site 
FAPY Formamidopyrimidine 
Kf   Klenow fragment  
DBU 1,8-Diazabicyclo[5.4.0]undec-7-ene  
THF Tetrahydrofuran  
dNTPs deoxynucleoside 5′-triphosphates  
Pol I DNA polymerase I  
Fam Carboxyfluorescein 
 PAGE Polyacrylamide gel electrophoresis 














1.1 DNA Damage and Mutation 
Deoxyribonucleic acid (DNA) is a molecule that encodes the genetic instructions used in 
each living cell; its integrity and stability are essential to life. The sequence of bases in 
the interior of DNA double helix constitutes the genetic code that is critically important 
for all organisms. Each strand is comprised of a sugar-phosphate backbone and attached 
bases, and is bound to a complementary strand by non-covalent hydrogen bonding and 
stacking interactions. The bases are adenine (A), thymine (T), cytosine (C) and guanine 
(G), where A and T are paired together by two hydrogen bonds and G and C are paired 
together by three hydrogen bonds (Figure 1.1). The chemical view of DNA acknowledges 
the unique shape of each base and position of the functional groups that distinguish the 
four ‘letters’ of the alphabet.  The twisting of the double helix results in the DNA having 
two distinct grooves, the major and minor grooves. The major groove is shallow and wide 
and this is where many proteins and enzymes interact with DNA. The minor groove is the 
deep and narrower groove. Chemical modifications on DNA can change the shape, 
electrostatics, or conformer distribution of the duplex. These changes enable enzymes to 
specifically recognize chemical modifications. This type of specific molecular 
recognition has a profound implication for DNA damage repair, gene mutation, and 





           
Figure 1.1 DNA base pairing (G with C and A with T), and the major and minor grooves. 
 
Cellular DNA is constantly subjected to modifications by aging processes, 
environmental influences, and lifestyle factors such as smoking- or diet-induced 
biochemical alterations to DNA. Frequently, these lead to DNA lesions. Although DNA 
lesions play an essential role in the formation of cancer via carcinogens, it is also one of 
the major mechanisms used for the treatment of cancer via chemotherapeutic agents and 
radiation therapy. When chemotherapeutic agents are used for the treatment of cancer, the 
biological end points can lead to either a positive clinical outcome (killing the cancer 
cells) or a negative outcome (mutations leading to secondary cancers from the initial 
treatment). This mixed cytotoxic and genotoxic effects were observed in the early 
development of chemotherapeutic agents such as Dacarbazine and Procarbazine.
1
 The 
determining factor on whether the damage will lead to cell death or mutations is the 
processing of the damage by the cell. DNA damages and mutations differ in fundamental 
ways. Damages are physical irregularities in the DNA, such as the formation of DNA 
adducts and single- and double-strand breaks. They also include the formation of 
mismatched nucleobases arising from erroneous replication of undamaged nucleosides. 
Because damage can be recognized enzymatically, they can be correctly repaired if 





transcription of the gene, and thus production of a protein or it can be incorrectly 
replicated or transcribed, causing mutations. On the other hand, a mutation is a change in 
the base sequence of the genetic material and is not enzymatically recognizable at the 
DNA level once the base change is present in both strands. Mutations can be caused by 
poor replication of damaged DNA or undamaged DNA, although the error rate on 
damaged DNA is much higher. Mutations in a cell can cause alterations in protein 
function or regulation.
 
They are replicated when the cell replicates. In a population of 
cells, mutant cells will increase or decrease in frequency according to the effects of the 
mutation on the ability of the cell to survive and reproduce.  
Therefore, although distinctly different from each other, DNA damages and 
mutations are closely related. Numerous DNA lesions have been identified, including 
covalent modifications of nucleobases with chemicals, depurination from the backbone of 
DNA, oxidative damage on deoxyribose, and subsequent generation of DNA strand 
interruption resulting from depurination and sugar oxidative damage.
2 
Naturally 
occurring DNA damages arise more than 60,000 times per day per mammalian cell.
2
 
Fortunately, our cells have evolved powerful mechanisms to detect and repair the various 
types of damage that can occur to DNA. Whether this damage is caused by chemical 
reactions or by errors in replication of undamaged nucleosides, it is repaired by one of the 
three excision repair pathways: nucleotide excision repair (NER), base excision repair 
(BER), and DNA mismatch repair (MMR). BER is responsible primarily for removing 
small, non-helix-distorting base lesions from the genome, for example, alkylation damage 
such as the formation of N7-methylguanine (N7-Me-G), N3-methyladenine (N3-Me-A) 







The related nucleotide excision repair pathway repairs bulky helix-distorting 
lesions. If remaining unrepaired, damaged bases could otherwise cause mutations by 
mispairing during replication or lead to strand breaks in DNA. DNA mismatch repair is a 
system for recognizing and repairing erroneous insertion, deletion, and mis-incorporation 
of bases that arise during DNA replication and recombination. 
 
                              
Figure 1.2 Structures of DNA base lesions. 
 
 During the cell cycle, checkpoint mechanisms ensure that cellular DNA is intact 
before permitting DNA replication and cell division to occur. Failures in these 
checkpoints can lead to an accumulation of damage, which in turn leads to mutations or 
epigenetic alterations.
3
 Both of these types of alteration can be replicated and passed on 
to subsequent cell generations. These alterations can change gene function or regulation 





Among them, the biological effects of DNA methylation have long been an interest of 
researchers, especially those on the formation of cancers. 
 
1.2 DNA Methylation 
Humans are exposed to methylating agents in daily life.
4
 The attack on DNA by these 
electrophilic methylating agents can lead to various types of lesions on the heterocyclic 
bases or backbone (Figure 1.3). Most of these resulting adducts are mutagenic or 
cytotoxic. The nucleophilicities of different reaction sites in DNA have been well studied. 
The exocyclic amino groups of guanine, cytosine, and adenine are poor nucleophiles in 
methylation reactions. Although each ring nitrogen and exocyclic oxygen is potentially 
capable of acting as a nucleophile, their reactivity towards electrophiles substantially 
varies by position and whether the DNA is single- or double-stranded. The most reactive 
sites of nonenzymatic DNA methylation (see next paragraph) are the ring nitrogen’s of 
purine bases. Among them, the N7 position of guanine is the most nucleophilic site.
5
 
Molecular electrostatic potentials of the nucleophilic sites on the bases and base pairs 
showed that the N7 position of guanine possesses the highest negative electrostatic 
potential in DNA.
6
 In double-stranded DNA, O6-guanine and N3-adenine have the next 
highest potential, followed by N3-guanine, O2-cytosine, N7-adenine, O4-thymine and 
O2-thymine.
6
 The negative electrostatic potential is larger on the major groove for a 
guanine:cytosine base pair, whereas it is larger on the minor groove for an adenine: 





                                                                                   
 
Figure 1.3 Methylation patterns of the DNA bases. (The arrows indicate methylation 
sites.
4
 )   
 
 
In single-stranded DNA, it is worth noting that N3-cytosine has a similar negative 
electrostatic potential to that of N7-guanine, while N1-adenine has a similar potential to 
that of O6-guanine.
6
 N1-adenine and N3-cytosine have a reactivity characteristic of 
amidine groups due to the adjacent amino groups on the neighboring carbons. These two 
positions are protected by hydrogen bonding in double-stranded DNA (dsDNA) but are 
quite nucleophilic in single stranded DNA (ssDNA) due to the absence of hydrogen 
bonding participation. The pKa’s of these two nitrogen sites are 4.1 and 4.5 in ssDNA, 
which are higher than that of N7-guanine.
7
  
Consideration of electrostatic potentials and steric hindrances help in part explains 
the reaction preferences seen with methylating agents, but the type of agents also 
influences the distribution of adducts. Methyl methanesulfonate (MMS), dimethyl sulfate 
(DMS), N-methyl-N-nitrosourea (MNU), and N-methyl-N′-nitro-N-nitrosoguanidine 
(MNNG) have been used extensively to study the chemical and biological effects of 
methylation. Understanding of the distribution is important for the evaluation of 
methylating outcome, as different lesions also have different mutagenic and cytotoxic 
effects. For example, it was observed that N7-methyl-dG (
7Me





when DNA was exposed to all the above methylating agents.
8 
However, the reactions 
occur through two different pathways: the SN1 (unimolecular nucleophilic substitution) 
and the SN2 (biomolecular nucleophilic substitution) pathways. (Figure 1.3); The SN1 
type methylating agents such as MNU and MNNG, also attack on the oxygen atoms on 
DNA bases to give a significant amount of O6-methylguanine (O6-Me-G) and a small 
amount of O4-methylthymine (O4-Me-T).
9 
The SN2 type methylating agents such as 
MMS and DMS generate overwhelmingly N7-Me-G.
9
 Experimental data show that 
treating dsDNA with MMS (SN2 type methylating agent) produced 83 % of N7-Me-G  
whereas MNU ( SN1 type methylating agent) produced 67 % of N7-Me-G.
4
 The more 
significant difference in reactivity between MMS and MNU lies in the proportion of 
oxygen adducts. In addition to N7-Me-G, MMS produced 11% N3-methyladenine (N3-
Me-A) and 0.3%  O6-Me-G, whereas MNU produced 12% N3-Me-A and 7% O6-Me-
G.
10
 The remaining base positions N1-adenine, N7-adenine, N1-guanine, N3-guanine, 
N3-cytosine, O2-cytosine, N3-thymine, O2-thymine, and O4-thymine combined 
comprise <5% of the adduct burden in dsDNA produced by MMS or MNU.
10
  
The events of human DNA methylation in daily lives originate from a wide 
variety of sources, including foods, beverages, tobacco, cosmetics, and industrial 
products.
11
 Detailed understanding of the biochemical fate of methylation adducts 
becomes extremely important. Although the N7-position is the major site of methylation, 
compared to many other DNA adducts, N7-guanine adducts are chemically unstable with 
half lives in dsDNA ranging from as little as 2 h to 150 h.
12
 The instability of N7-guanine 
adducts is created by the formal placement of an additional positive charge on the 
guanine ring system.
4





which leads to cytotoxicity, numerous studies have suggested that N-methyl-G itself is 
not very mutagenic. In contrast, O-alkylations (e.g., O6-alkylguanine and O4- 
alkylthymidine) are highly mutagenic based on a variety of solid evidence.
13
 
Nevertheless, we chose to study N7-methyl-dG (
7Me
dG) since direct observation of the 
nonmutagencity of N7-methyl-dG is lacking at the molecular level in vitro due to its 
instability. N7-guanine adducts have been classified as nonmutagenic based on the 
speculation that the N7-position  does not participate in Watson-Crick base pairing.
14
 
However, this information can only be verified experimentally by the study of how DNA 
polymerases process the damage which is an essential step in the eventual biological 
endpoint of the damage. Because of its inherent instability 
7Me
dG has been unable to be 
chemically synthesized and incorporated into oligonucleotide substrates suitable for DNA 
polymerase assays. Using the stable analogues of 
7Me
dG, we have developed a strategy to 
generate models of 
7Me
dG-containing substrates, which are suitable for the study of their 
interactions with DNA polymerases. This is the focus of my first project. 
 
1.3 DNA Methylation and Epigenetics 
 In contrast to exogeneous agents, methylating agents also exist endogenously inside 
cells; for instance, S-adenosylmethionine(SAM), a methyl donor for many cellular 
reactions, has  been shown to produce methylation products such as epigenetic DNA 
modification 5-methylcytosine (MeC). There are over 200 different types of cells in the 
human body. Each type maintains a unique cellular identity represented by the specific 
sets of genes they transcribe. Because the genetic material in each of these cells is 





the human body. This transcriptional regulation is carried out by controlling the 
accessibility to genes. This layer of control is achieved by the packaging of DNA into 
particular arrangements. DNA is wrapped around proteins called histones, which are 
structurally organized and condensed into chromatin. Histone proteins can be modified, 
and these modifications serve as important regulators in the transcription of necessary 
genes throughout the life cycle of an organism. In mammals, the methylation on specific 
sites of DNA called CpG islands is an additional method of transcriptional control. In 
nucleic acid chemistry, adjacent nucleotide pairings are sometimes referred to in an NpN 
fashion, where N is the base and p is the phosphodiester bond; thus, CpG is the 
designation given to cytosine phospho guanine. The frequency of the CpG dinucleotide is 
very low (or rather, sporadic) in the human genome. It has been estimated that genomic 
DNA consists of about 10% CpG dinucleotides, which are unevenly distributed between 
bulk DNA and CpG islands.
15
 Histone modifications and CpG island methylation are 
collectively called epigenetic; a term defined as heritable changes in gene expression that 
occur without a change in the DNA sequence.  
Previously, scientists have attributed a person phenotype’s characteristics based 
solely on the composition of the persons genomic DNA. It is through the genetic 
composition and alterations that we have studied the neoplastic evolution and were 
confounded to the idea that cancer was mainly a disease of genetics. Recently, the study 
of external influences on the DNA has come to question this idea in favor of a much 
larger complex mechanism which involves the abnormal epigenetic control. Epigenetic 
control at the chromatin level is essential for all eukaryotic organisms, and is especially 





differentiation, imprinting, X-chromosome inactivation and aging. Cellular differentiation 
is the best example of epigenetic changes. All multi-cellular organisms, including 
animals originate from a single cell after fertilization of an egg by a sperm. Therefore all 
cells in a given organism will have the same genome, but during fetal development each 
cell will gain a specific set of epigenetic marks. DNA methylation is such an epigenetic 
mark that stably regulates cell differentiation. While uncontrolled cell differentiation is a 
character of cancer cells, understanding of the relationship between DNA methylation 
regulation and cancer formation becomes critical in elucidating this complex mechanism.             
Uncontrolled differentiation is often a result of silenced cancer-suppressor genes. 
CpG islands are normally not methylated, however, if a CpG island within a promoter 
becomes methylated, the gene associated with the promoter is permanently silenced, and 
this silencing can be transmitted through mitosis. This means that CpG island 
methylation is an epigenetic means of inheritance. So far, the generally accepted 
mechanism of DNA methylation in regulating gene expression and gene silencing can be 
classified into two mechanisms. The first is that CpG methylation alters the secondary 
conformation of DNA from the B form to the Z form, a much more compact form with a 
deeper groove. This disrupts the interactions between specific transcription factors and 
gene promoters, consequently resulting in the direct inhibition of gene transcription.
16
 
The second mechanism is that CpG methylation leads gene regulation regions near the 5′ 
end to complex with methyl CpG-binding protein (MBD).
17
 Under the network of 
mCpG-MBD complexes, histones become more positively charged and bind more tightly 
with DNA, making chromatin more compact. Thus, the binding of transcription factors 





1.4 DNA Methylation and Cancer 
 Early studies using global measurement of 5-methylcytosine content in normal and 
neoplastic tissues suggested that decreased DNA methylation levels is a common feature 
of cancer.
18 
However, a more recent study by Costello et al. (2000) suggested that 
relationship between the global methylation levels and cancer formation is dependent on 
the type of cancer cells., Certain tumor types, like breast, head and neck, and testicular, 
displayed a relatively low frequency of aberrant methylation while other tumors such as 
colon, glioma, and acute myeloid leukemia, displayed a significantly higher frequency of 
aberrant methylation events. It was estimated that an average of 608 (up to as many as 
4500) CpG islands were aberrantly hypermethylated in tumors.
19
 Methylation 
abnormalities were detectable in both low and high-grade malignancies, supporting the 
notion that methylation changes can be an early event in tumor progression. Furthermore, 
CpG island methylation was not random indicating that certain CpG islands may be more 
susceptible to de novo methylation than others or that selective loss of expression from 
certain CpG island associated genes may be favored if loss of that gene provides the cell 
with a growth advantage.   
The reaction of CpG island methylation features the addition of a methyl group at 
the carbon-5 (C5) position of cytosine residues. The level of CpG island methylation is 
controlled by DNA methyltransferase (DNMT), an enzyme that catalyzes the transfer of a 
methyl moiety from SAM to the C5 position. All DNMTS are essential for normal 
development, as it was shown that mice lacking any of the DNMTs died at fetal 
development stage or early after birth.
20
 The mammalian DNMTs family encompasses 











The maintenance DNMT1 is the most abundant methyltransferase in mammalian 
cells. It transfers methyl groups to the hemimethylated DNA during replication, whereas 
the de novo DNMT3A and DNMT3B add methyl groups to CpG dinucleotides of 
unmethylated DNA (Figure.1.3). Hemimethylated DNA is referred to as a duplex DNA 
where only one of two (complementary) strands is methylated (Figure.1.4). A 
hemimethylated site is a single CpG that is methylated on one strand, but not on the 
other. Hemimethylation is important because it directly identifies de novo methylation 
events, allowing differentiation between de novo vs. maintenance factors. The structure 
of mammalian DNMTs can be divided into two major parts, a large N-terminal regulatory 
domain of variable size, which has regulatory functions, and a C-terminal catalytic 







Figure 1.5 Members of mammalian DNMTs family. The N-terminus of DNMT1 
includes a proliferating cell nuclear antigen binding domain (PDB), nuclear localization 
signal sequence (NLS), a cysteine rich zinc finger DNA binding motif (ATRX),  
polybromo homology domain (PHD); while Dnmt3a and Dnmt3b consist of a 






The N-terminal regulatory and the C-terminal catalytic domains are linked by a 
short fragment of repeated GK dipeptides. The N-terminal domain possesses nuclear 
localization signal sequence (NLS) responsible for localization of DNMTs in the nucleus. 
The N-fragment of DNMTs also contains proliferating cell nuclear antigen binding 
domain (PDB), a cysteine rich zinc finger DNA binding motif (ATRX), and polybromo 
homology domain (PHD) targeting DNMTs to the replication foci. However, PWWP, a 
tetrapeptide that interacts with histones, is only present in N-terminal domains of 
DNMT3A and DNMT3B.
25
 The C-terminal domain contains six conservative motifs I, 
IV, VI, VIII, IX and X. Motifs I and X form SAM binding site, motif IV binds cytosine at 
the active site, motif VI possesses glutamyl residue donating protons, and motif IX 
maintains the structure of the target recognition domain (TRD) usually located between 
motifs VIII and IX, that makes base-specific contacts in the major groove of DNA.
26 
In 
contrast to DNMT1, C-terminal domain of DNMT3A and DNMT3B is active without 





novo DNMTs may provide the structural basis for the design of selective DNMT1 
inhibitors. 
Since many tumors suppressor genes are silenced by DNA methylation during 
carcinogenesis, Reexpression of methylation silenced tumor suppressor genes by 
inhibiting the DNMT can lead to suppression of tumor growth or provide novel 
opportunities for anticancer therapy. Inhibition of the activity of these proteins will 
therefore result in progressive reduction of DNA methylation in newly dividing cells. My 










N7-methylated guanine adducts are the most abundant products when DNA is exposed to 
many methylating agents found in industrial products, food substances, and tobacco 
smoke. Methylating agents constitute one of the best studied groups of model genotoxic 
chemicals, represented by such laboratory classics as, N-methyl-N-nitrosourea (MNU), 
methyl-N′-nitro-N-nitrosoguanidine (MNNG) and methyl methanesulfonate (MMS). In 
addition to their wide use in experimental genetic toxicology, methylating agents are of 
interest in view of the known human exposure to them and the possible genetic risks 
associated with it. Relatively small population subgroups suffer limited workplace 
exposure to weakly genotoxic methylating chemicals such as dimethyl sulfate (DMS) and 
methylbromide.
27
 On the other hand, of potentially greater public health significance is 
the exposure of the general population to strongly carcinogenic methylating agents such 
as N-nitrosodimethylamine (NDMA) and 4-methylnitrosamino-1-3-pyridyl-1-butanone 
(NNK). These nitrosamines are present in significant quantities in tobacco smoke, while, 
in addition, NDMA is also found in nitrate- or nitrite-treated foods, certain beverages, 
and certain occupational settings.
11, 28 
Although neither NDMA nor NNK is reactive 
toward DNA, they can be converted by liver cytochrome P450 enzymes to the highly 











      
 
Figure 2.1 Formation of N7-Methyl-dG (
7Me




DNA methylation can occur "naturally" as well. There are also endogenous 
methylating agents such as SAM, which is required for the enzymatic conversion of 
cytosine into 5-MeC as part of the DNA methylation pathway that helps regulate gene 
expression. Alternatively, SAM can act as a weak DNA methylating agent through 
nonenzymetic reactions.
29
 Human can also be exposed to methylating agents during 
chemotherapy. Dacarbazine and Procarbazine are two known anti-cancer agents that 
produce DNA methylation on N7 position of guanine.
1
 
However, N7-Me-dG is difficult to study due to its short lifetime. This low 
stability presents a challenge for chemists to prepare oligonucleotides containing N7-Me-
dG using the standard phosphoramidite chemistry. The cationic base would have been 
cleaved by nucleophiles at various stages if the standard phosphoramidite of 7-MeG were 
to be synthesized. In addition, the N7-Me-G would not survive the oligonucleotide 
deprotection conditions after the solid phase synthesis. On the other side, the fact that 





of in vivo mutagenic data problematic. Precise understanding of the mutagenic effects of 
N7-Me-G is an important task for chemists and biochemists. This chapter describes the 
chemical synthesis of stable analogues of N7-Me-G. 
 
2.1.1 Biological Significance of N-Methyl and O-Methyl Adducts 
Exposure of mammalian cells to methylating agents causes transfer of methyl groups to 
N- as well as O-atoms of DNA bases. The structural and biological consequences of the 
different N- and O-methyl adducts have been studied to various extents. Methylation at 
oxygen atoms results in DNA lesions, especially O6-Me-G which has been shown to be 
strong inducers of gene mutations.
30
 Yet many methylating agents react much more 
frequently with nitrogen atoms than with oxygen atoms in the DNA, resulting in high 
proportions of N7-Me-G and N3-Me-A in DNA adduct. Studies using DNA templates 
treated with methylating agents and purified polymerases established the dogma that N7-
Me-G does not block replication and is perhaps not miscoding, but its depurination 
produces an apurinic (AP) site, which if not repaired can be mutagenic and cytotoxic, 
whereas N3-Me-A has been predicted as a replication fork blocking lesion. Structural 
studies of DNA polymerases suggest that minor groove N3-purine and O2-pyrimidine 
contacts are important during extension from newly synthesized base pairs, thus 




 Methylation at the N3 site of adenine, which lies in the minor groove, has been 
shown to result in cytotoxicity, but not mutations by high-fidelity polymerases.
32
 N3-Me-





give rise to a chemically or enzymatically generated AP site.  Thus, compounds that can 
generate exclusively N3-Me-A adducts can be used to destroy cells without any risk of 
mutagenicity. For example, minor groove specific methylation reagent such as Me-Lex 
has been suggested to play such a role.
32
 N3-Me-A is a quantitatively significant DNA 
adduct formed from the reaction of many methylating agents. However, it is also in 
combination with a large number of other DNA lesions, including N7-Me-G, O6-Me-G, 
and N1-Me-A.
 
In a previous study on the potential effect of N3-Me-A on DNA 
replication, MMS  and DMS, which predominantly react with DNA to produce N7-Me-
G, were used to methylate poly(dA-dT).
33 
Under these conditions, the heteropolymer 
contained a mixture of N3-Me-A, N1-Me-A, and N7-Me-A adducts in a ratio of 16: 3: 1. 
Replication of this template by E. coli DNA polymerase I decreased proportionally to the 
level of total methyl lesions and/or abasic sites. The reduction of DNA polymerization is 
likely to be caused by the N3-Me-A lesions.
34
 In contrast to error-free polymerases, in 
vitro bypass study on a stable analogue of N3-Me-A showed that bypass polymerases 
such as eukaryotic Y-family polymerases can efficiently replicate N3-Me-A, although 
with significantly higher error rates.
35
  
           Unlike adenine, guanine methylation occurs mainly at the N7-position. Initially 
N7-Me-dG (
7Me
dG) was thought to be responsible for the high G→A transition rate 
observed for the methylation of DNA. This assumption was indirectly supported by the 
fact that 
7Me
dG has a low pKa and should form a mispair with dT as a zwitterions.
36
 
However, this became questionable when O6-methyl-dG, another guanine adduct that 
induces G→A transitions, was discovered (see the next paragraph).
37
 Another 





the first N7-guanine adduct, several hundred studies on DNA adducts have been reported. 
The instability of N7 purine adducts has prevented more through studies of these adducts 
via site-specific approaches. Two hydrolysis pathways contribute to the instability of  
N7-Me-dG (Figure 2.2). Hydrolysis of the imidazole ring gives FAPY 
(Formamidopyrimidine) products which are weakly mutagenic. Studies have shown that 
the ring opened methyl-formamidopyrimidine adduct of N7-Me-G can block E. coli DNA 
polymerase Klenow fragment (Kf polymerase) in vitro,
38, 39
 However, the 
misincorporation frequencies are significantly higher when error-prone polymerases are 
used. Significant misincorporation of T was observed when N7-Me-FAPY-G was 
bypassed by human polymerases η and pol κ.
40
 Hydrolysis of the glycosidic bond either 
by a spontaneous process or an enzymatic repair mechanism gives AP site which is 
known to have mutagenic and toxic consequences. Replication of AP sites by translesion 
synthesis polymerases finishes with predominately deoxyadenosine incorporated.
41
 These 
misinsertion events are responsible for the G→T transversions, the major mutations 












            On the other hand, oxygen-centered base methylation adducts are directly 
mutagenic and much current evidence suggests that the most abundant of these, O6-Me-
G, plays a major role in mutagenesis and carcinogenesis. O6-Me-G mispairs with 
thymine during DNA replication, which gives rise to a transition mutation of G:C to 
A:T.
37
 The structure of O6-Me-G:T base pair was recently observed in a crystallography 
study. Although O6-Me-G is readily replicated and does not produce secondary lesions, it 
can be cytotoxic by being processed by MMR. This process results in long single-strand 
patches; if that overlaps another O6-Me-G site of repair on the opposite strand, MMR can 
generate double-strand disruptions or breaks.
42
 Other than O6-Me-G, O2-cytosine and 
O4-thymine (Figure 2.3) can also react with methylation agents presumably because they 
are not blocked by hydrogen bonding, and the extra pair of electrons available at oxygen 
is free to react, even in a double-stranded form. O4-Me-T has been examined as a site-




                           





In contrast, N1-adenine and N3-cytosine (Figure 2.3) are not very reactive toward 
methylation reagents due to the hydrogen bonding participation, although these two sites 
are much more susceptible to methylation in single stranded DNA. A more recent study 
using site specific adducts in vectors passed through E. coli found that N3-Me-C was 
more mutagenic than N1-Me-A, whereas both adducts blocked replication.
20
 The N1-
guanine and N3-thymine are secondary amines that have adjacent carbonyl groups and 
are thus less reactive, the rare N1-Me-G and N3- Me-T (Figure 2.3) adducts were also 
shown to be mutagenic and replication blocking.
44 
           In summary, O-methylation products (e.g., O6-Me-G and O4-Me-T) are highly 
mutagenic, whereas the mutagenicity of N-methylation products (e.g., N3-Me-A and N7-
Me-G) are weak but not clearly understood because of the possibilities of generating 
secondary DNA lesions or recruiting error-prone polymerases. In general, the studies of 
mutagenicity of DNA methylation adducts are challenging questions due to the 
uncontrolled product distribution, the presence of secondary lesions, and the involvement 
of multiple polymerases and repair enzymes. 
 
2.2 Need for Stable Analogues of N7-Methyl-Guanine                      
The best way to precisely understand the mutagenic potential of a DNA lesion resulting 
from misincorporation is to study the relative rate of dNTP incorporation by each 
polymerase (See chapter 3). The low stability of N7-methylguanine becomes an obstacle 
to synthesize oligonucleotides containing a single N7-methylguanine for the analysis of 
DNA polymerase bypass. In fact, the only N7-alkylguanine that has been synthesized and 
used for such a bypass study is the aflatoxin B1 (AFB1) N7-guanine adduct.
45
 Reaction 





applicable to N7-methylguanines. Other reported synthetic N7-methylguanines were only 
produced as randomly distributed mixtures, and more often together with other types of 
low-abundance guanine adducts.
46
 The results were typically analyzed by looking into the 
in vivo mutation map on a certain gene, or the composition percentage of digested 
nucleotides after in vitro polymerase reactions. A problem of interpreting these data is 
that many low-abundance guanine adducts are in fact much more mutagenic than N7-
methylguanines. Their contribution to the observed mutation is difficult to estimate. For 
example, when methylation reagents such as NDMA and MMS react with guanine, O6-
methylguanine is also observed. Therefore researchers often attribute all observed G→A 
transitions in vivo to the formation of O6-Me-G. This attribution is strongly backed by 
the result of an in vivo study which showed the amount of O6-Me-G, not N7- Me-G, 
correlated with the G→A transition events.
37, 47, 48
 However, the recent discovery that N7-
Me-FAPY-G, which is generated from N7-Me-G, may also causes G→A transitions has 
made the interpretation more complicated.
39, 40
 In contrast to the well studied G→A 
transitions, other guanine mutation were often overlooked or explained only by 
speculations. For example, G→T transversions were explained by the formation of abasic 
sites from N7-Me-G, although repair-enzyme knockout experiment results were 
contradictory.
49
 Alternatively, G→T transversions were explained by the potential 
mutagenic effect of N3-Me-G, which in fact was as poorly understood as N7-Me-G.
50
 In 
addition, G→C transversions observed in Chinese hamster ovary cells were overlooked.
51
 
Despite the ambiguity of the in vivo mutagenesis data, other indirect evidence does 
support that N7-Me-G is non-mutagenic. First, thermal stability and structural studies of a 





disrupt normal duplex formation.
52, 53
 This DNA duplex was synthesized by incorporating 
the triphosphate of N7-Me-G. Similar single-stranded DNA containing N7-Me-G was not 
reported, probably due to the difficulty to separate the two strands without the risk of 
hydrolyzing the N7-Me-G. Second, nucleotide composition analysis of the replication 
products of an RNA template containing randomly formed N7-methylguanosine showed 
that N7-Me-rG did not increase the amount of UTP incorporated by RNA-dependent 
RNA polymerase,
46
 although the margin of error determined that the best conclusion one 
can draw is that N7-Me-rG is not very mutagenic on RNA replication.  
           In summary, N7-Me-G does not appear to have the tendency to incorporate 
mismatched nucleosides at abnormally high frequencies. The N7 cationic charge does not 
have significant impact on the ionic state of the base as was first proposed in the 1950’s. 
However, the exact misincorporation frequencies opposite N7-Me-G would never be 
determined if the technologies in synthesizing and handling unstable nucleosides remain 
restricted.  
2.3 Design of the Analogue N7-Methyl-Guanine 
A stable analogue of an unstable DNA lesion can provide a good model to study its 
various biophysical and biochemical properties. Huang and Greenberg
54
 previously made 
structural analogues of oxidized abasic site and discovered that the analogues were 
replicated in a way similar to the natural lesion. Verdine 
55
 reported N7-Me-2’-F-dG as a 
stable analogue of N7-Me-dG and used it to trap 3-methyladenine DNA glycosylase II 
(AlkA), the repair enzyme of N7-Me-G and N3-Me-A. However, the 2’-F group is 





 recently used 7-deaza-dG as a stable analogue to study nitrogen 





Me-3-deaza-dA to study the bypass.
35
 The result showed 3-Me-3-deaza-dA was a 
stronger blocker of error-free DNA polymerases. The same analogue was recently used to 
trap AlkA for structural determination.
58
 These neutral isosteres of alkylated purines 
should serve as the general replacement for structural or bypass studies. However, the N-
glycosidic bond of these isosteres could be repaired by BER enzymes. For example, 7-
Me-7-deaza-G, a chemically stable analogue of N7-Me-G, can be removed by E. coli 
BER enzyme Formamidopyrimidine [fapy]-DNA glycosylase (Fpg) (See chapter 4). It 
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Hence, the best structural analogues of N7-methylguanine should fulfill the 
following requirements.  
1. The structure is stable and can be synthesized via the phosphoramidite chemistry.  
2. The structure is stable against the actions of BER enzymes.  
3. The structure is modular for the preparation of other N7-alkylG adducts for future 




dG) was selected as the analogue.7-Methyl-
7-deaza-dG (
7Me7C





2.4 Synthesis of 
7Me9C
dG Phosphoramidite 
This synthesis requires preparation of 9-deazaguanine which was originally prepared by 
Gibson
60 
et al (Scheme 2.1). In their study, the synthesis of 9-deazaguanine was 
synthesized by using the commercially available 2-amino-6-methylpyrimidin-4(3H)-one 
as a starting material.  The 9-deazaguanine was prepared in 5 steps. Nitration of starting 
material afforded in compound 2. Treatment of 2 with N, N-dimethylformamide (DMF) -
dimethylacetal at room temperatures afforded the corresponding derivative 3. The 
exocyclic amino group of 3 was protected with dmf (Dimethylformamide). The N1 
Position of derivative 3 was protected with a benzyl group by treatment of benzyl 
bromide in the presence of 1,8-Diazabicyclo[5.4.0]undec-7-ene (DBU), giving derivative 
4. The 6-amino group of 4 was further protected with dmf at elevated temperature and 
converted to derivative 5. Derivative 5 upon reductive cyclization was converted to N1-
benzyl-9-deazaguanine (6) in an 89% yield (Scheme 2.1). 
The same strategy, with slight modifications, was used to synthesize our target 
molecule (7) (Scheme 2.2). However, we experienced some difficulties in converting 5 to 
6. All our attempts resulted in recovery of the starting material. In contrast to the original 
synthesis in which they used a saturated solution of Na2S2O4 mixed with tetrahydrofuran 
(THF) ,we found that the solubility of compound 5 was very low in the aqueous-THF 
mixture, so we synthesized compound 6 using DMF as the co-solvent and at an elevated 
temperature (65
o 
C). Compound 6 was subjected to a methylation reaction using methyl 
iodide as the reagent. The reaction initially proceeded poorly. Careful analysis of the 1H 
NMR of the starting material suggested that it might have been difficult to remove 





high vacuum overnight, the reaction still suffer from low yields. Finally, it was proved 
that this reaction was very sensitive to water and thus the solvent THF needs to be dried 
under vigorous conditions. The yield was improved to 45% when THF was treated with 
LiAlH4 under reflux conditions for more than 16 hours. 
 
 




 (a) H2SO4, HNO3, 50°C, 1 
h,80%;  (b) DMF-dimethylacetal,CH2Cl2, rt, 1 h,92%; (c)  DMF , DBU, Benzyl bromide, 
rt, 2 h,QY; (d)  dry DMF, DMF-dimethylacetal 80
o




















Scheme 2.2 Synthesis of the Nucleobase 
7Me9C
G. (a) H2SO4, HNO3, 0°C, 3 h,88%;  (b) 
DMF-dimethylacetal,CH2Cl2, rt, 2 h,74%; (c)  DMF , DIPEA, Benzyl bromide, r.t., 16 
h,85%; (d)  DMF, DMF-DMAC, 65
o
C, 4 h,70% (e) DMF, Na2S2O4 , 65
o
C, 2 h,84%; (f)  




The glycosyl donor 1-(a,b)-O-Methyl-3,5-di-(O-p-toluoyl)-2ʹ-deoxyribose was 
prepared according to a reported procedure (Scheme 2.3).
61
 The commercially available 
D-2-deoxyribose was treated with methanoic HCl which was generated in situ from 
acetyl chloride and methanol. This reaction gave the O-methyl acetal of 2ʹ-deoxyribose. 
The 5ʹ- and 3ʹ-hydroxyl groups of 2ʹ-deoxyribose were then protected with O-toluate by 





            
Scheme 2.3 Synthesis of Protected Methyl Glycoside of 2ʹ-deoxyribose. (a) D-2-
deoxyribose, CH3COCl, MeOH, rt, 4.5 h (b) DMAP, p-Toluoyl chloride, dry pyridine, rt, 
16 h, 43% overall.  
 
 
The C-glycosidic bond of N7-methyl-9-deaza-dG was formed via condensation of 
7 and 8. SnCl4 was used as the Lewis acid to activate the O-glycosidic bond of 8, leading 
to the formation of oxycarbenium ion, which underwent a Friedel-Crafts reaction with the 
electron-rich C9 position of N7-methyl-9-deazaguanine. This reaction was affected by a 
variety of factors (Table 2.1). In general, a 1:1 mixture of methylene chloride and 
acetonitrile is a better solvent system than nitromethane, which was the solvent that 
Gibson used to prepare 2ʹ-deoxy-9-deazaguanosine. The inclusion of methylene chloride 
is critical as it increases the solubility of the starting material. The molecular ratio of 
SnCl4 to the base also affected the yield. Larger amount of SnCl4 afforded significantly 
higher yields. The optimal yield obtained in this reaction was 40%, much higher than that 
reported by Gibson for the 2ʹ-deoxy-9-deazaguanine synthesis. This difference may be a 
result of the electron-donating effect of the N7-methyl group. However, it is more likely 
that reaction optimization contributed to the higher yield in our experiments. After 
compound 9 was synthesized, the remaining steps were all protection and deprotection 
reactions. Initially, we planned to use dmf as the protecting group for the exocyclic amine 
for oligonucleotide synthesis, as it was already installed in the early stage of the 
synthesis. Later, we found that dmf on compound 9 was very robust and could not be 





deprotection of dmf would likely be problematic, if it were used for oligonucleotide 
synthesis, although it was also possible that the adjacent benzyl group blocked the 
hydrolysis. Incorporation of non-methylated 9-deaza-dG (
9C
dG) into oligonucleotides has 
previously been reported on several occasions. Based on earlier studies we have changed 
our synthesis route and thought of replacing dmf with an isobutyryl group to protect the 
exocyclic amine. On the other hand, it was reported that C1 epimerization occurred 
during the deprotection of isobutyramide of 9-deaza-dG in concentrated aqueous 
ammonia at 55 °C for 12 h.
62 
One alternative solution was to use isopropylphenoxyacetyl 
(iPac), a more base-labile protecting group, allowing deprotection in ammonia at room 
temperature. However, another study on the deprotection of isobutyramide of a 2ʹ,3ʹ-
didehydro-2ʹ,3ʹ-deoxy nucleoside of 9-deazaguanine did not report obvious epimerization 
even if the reaction was carried out in saturated ammonia in ethanol at 80 °C for 20 h.
63
 
Therefore we decided to first try isobutyryl group for the protection of the exocyclic 
amine of 
7Me9C
dG. (See later paragraph) 
 
Table 2.1 Factors that Affected the Synthesis of 7-methyl-9-deaza-dG 
Entry SnCl4 
(eqn.) 
Solvent Time(hr) Temp. % Yield 
1 1.5 dry Nitromethane  16 h  60
o
C   0 
2 4 dry Nitromethane  16 h  60
o
C   10 
3 4 dry DMF 4 h  65
o
C   0 
4 4 dry DCM 4 h reflux 0 
5 4 dry CH3CN  4 h reflux 0 
6 4 
 dry CH3CN :dry 
DCM 4 h reflux 44 







Scheme 2.4 Synthesis of 
7Me9C
dG Nucleoside. (a) Compound 8 SnCl4, 1:1 (v/v)  dry 
CH2Cl2–CH3CN, reflux, 4 h, 44%; (b)0.4 M KOH in 1:1 (v/v) H2O–EtOH, reflux, 16 h, 
89%; (c) HCO2NH4, Pd/C, EtOH, reflux, 16 h, 46%. 
 
 
The dmf group of 9 was successfully removed in 0.4 M methanoic KOH under 
reflux conditions. No evidence for epimerization during deprotection was found. In the 
next step, cleavage of the benzyl group under catalytic hydrogenation conditions with 
Pd/C at 50 psi did not proceed. Substitution of Pd/C with the more reactive Pd (OH)2 /C 
showed no improvement. A literature survey showed that the benzyl protecting on the N1 
positions of hypoxanthine and guanine and the N3 positions of uracil and thymine
 64, 65
 is 
difficult to remove under normal hydrogenolysis conditions. Successful transformation 
requires a large amount of Pd
34
 catalyst or high temperature (over 100C)
66
. Concerned 
upon the safety risks of using large quantities of Pd/C or higher temperature, we decided 





cyclohexadiene as the hydrogen source was unsuccessful.
67
 Then ammonium formate 
was used as the hydrogen source, which successfully removed the benzyl group. The 
debenzylated compound 11 was obtained in 46% yield. TLC showed that starting 
material was not completely consumed. Ultimately, extension of the reaction time or 
adding more ammonium formate did not help improve the yield.  
 
 
Scheme 2.5 Synthesis of 
7Me9C
dG Phosphoramidite. (a) TMSCl, Et3N, CH2Cl2, 0.5 h, then 
isobutyric anhydride, dry pyridine, rt, 2 h, 68% (b) Dimethoxytrityl chloride, Et3N, 
DMAP, dry CH2Cl2, rt, 16 h, 60%; (c) 2-cyanoethyl N,N-








The phosphoramide of 
7Me9C
dG (7) was then prepared using standard protocols 
from 6.
68
 According to previous discussion, the exocyclic amine of the 
9C
dG was 
protected with an isobutyryl group. The compound 11 was converted to compound 12 via 
transient protection. When we tested our methylated nucleoside 12, we also found that it 
was fully deprotected and converted back to 11 in concentrated ammonia at 55 °C for 12 
hours with no evidence of epimerization. 
The 5ʹ-hydroxyl of 12 was protected as dimethoxytrityl (DMTr) ether. Initially we 
used pyridine as the solvent. However, the pyridinium salts generated in the reaction co-
migrated with the starting material on the silica gel column, making recovery of 
unreacted starting material difficult. Later we changed the solvent to methylene chloride. 
This change was reproducible and unreacted starting material can be easily recycled for 
same reaction. We found that the amount of DMAP and TEA has impact on the reaction 
yield. Increase of the amount of TEA from 1.5 eq. to 2 eq. and DMAP from 0.05 eq. to 
0.2 eq. resulted in improved yield (60%). The 3ʹ-hydroxyl was then activated as a 
phosphoramidite through standard chemistry to yield the solid phase synthesis-ready 





with 7, were incorporated into oligonucleotides: oligonucleotide 15, 16 (3ʹ- ACT CTG 
TXC TTC GAT G-5ʹ, where X = dG,
 7Me9C
dG respectively), oligonucleotide 17, 18, 19 







dG respectively) and 5ʹ-Fam labeled oligonucleotide 21, 22, 23 (3ʹ- TAC CTC TCT 







These oligonucleotides were used for the subsequent studies on thermal stability, 





2.4.1 Materials and Methods 
All chemicals were purchased from Sigma-Aldrich or Fisher Scientific unless specified. 
THF was dried over LiAlH4 and then distilled under Ar. CH2Cl2, pyridine, and 
acetonitrile were distilled over CaH. Compound 7 was synthesized from 6-
methylisocytosine in five steps according to a reported procedure.
60
 The only 
modification of the procedure was the last cyclization step where the solvent was 
changed from THF to DMF due to the limited solubility of the starting material. NMR 
spectra were recorded on a 300 MHz Bruker spectrometer. High resolution ESI-MS 
spectra were obtained in the mass facility at Rutgers University (Newark, NJ). 
Compound 2: To a mixture of 2-amino-6-methylpyrimidine-4(3H)-one (5 g, 40 mmol) 
in 25 mL of H2SO4 at 0C was added 4 mL HNO3 with an additional funnel. After being 
stirred at room temperature for 3 hr, the reaction mixture was slowly poured into 360 mL 
of diethyl ether and stirred for 15min.The liquid was decanted and the remaining solid 
was mixed 100 mL of ethyl acetate and was stirred for 10 h. The solid (6 g, 88% yield) 
was filtered and used for next step without any further purification. 
1
H NMR (300 MHz, 
DMSO-d6) δ ppm 2.26 (d, J=1.40 Hz, 3 H). 
 
Compound 3: To a suspension of 2 (6 g, 35 mmol) in methylene chloride (106 mL) 
DMF-dimethylacetal (12.1 mL) was added and the mixture was stirred at room 
temperature for 1.5 hour. The precipitated product was removed by filtration to give 3 
(5.86 g, 74%). 
1
H NMR (300 MHz, DMSO-d6) δ ppm 2.27 (s, 3 H) 3.08 (s, 3 H) 3.21 (s, 





Compound 4: To a suspension of compound 3 (6.55 g, 29 mmol) in DMF (143 mL),     
N, N-diisopropylethylamine (DIPEA) (4.70 g, 36.4 mmol) was added and the reaction 
mixture became clear. To this solution was added benzyl bromide (15.66 g, 92 mmol, 
over 1 h) and the mixture was stirred at room temperature overnight. The residue was 
dissolved in methylene chloride (200 mL). The solution was washed with sat. solution of 
NaHCO3 (3 x 100 mL), dried MgSO4 and concentrated. Trituration with methanol (150- 
200 ml) to give 4 (7.72 g, 85%). 
1
H NMR (300 MHz, CHLOROFORM-d) δ ppm 2.43 (s, 
2 H) 3.22 (s, 3 H) 3.30 (s, 3 H) 5.44 (s, 2 H) 7.23 - 7.36 (m, 3 H) 7.42 - 7.50 (m, 2 H) 
8.78 (s, 1 H). 
 
 Compound 5: To a suspension of compound 4 (7.72 g, 25 mmol) in DMF (30 mL) at 
65C DMF-DMAC (4.41mL) was added and the mixture was stirred at this temperature 
for 3-4 h until TLC analysis showed disappearance of the substrate. Concentration and 
trituration of the residue with methanol (150 mL) resulted in 5 (6.57 g, 70%). 
1
H NMR 
(300 MHz, CHLOROFORM-d) δ ppm 3.06-3.21 (m, 12 H) 5.36 (s, 2 H) 5.66 (d, J=12.21 
Hz, 1 H) 7.18 - 7.29 (m, 3 H) 7.40 (d, J=6.68 Hz, 2 H) 7.90 (d, J=12.21 Hz, 1 H) 8.57 (s, 
1 H). 
 
Compound 6: To a stirring solution of 5 (3.2 g, 8.6 mmol) in DMF (66 mL) maintained 
at 60-65C was added sodium dithionite (Na2S2O4, 23 g). Distilled water was added (180 
mL) gradually portion wise to this solution during a period of 30 min, until an orange 





room temperature and the yellowish white precipitate was collected by filtration and then 
washed with water to give 6 (2.11 g, 84%). 
1
H NMR (300 MHz, CHLOROFORM-d) δ 
ppm 3.06 (s, 3 H) 3.11 (s, 3 H) 5.61 (s, 2 H) 6.28 (t, J=2.50 Hz, 1 H) 7.10 (t, J=2.93 Hz, 1 
H) 7.17 - 7.32 (m, 4 H) 7.38 - 7.44 (m, 2 H) 8.48 (s, 1 H). 
 
Compound 7. To a stirring solution of compound 6 (0.610 g, 2 mmol) in dry THF (40 
mL) was added sodium hydride (83mg, 2 mmol). The reaction was stirred for 10 min 
before iodomethane (2.90 g, 20 mmol) was added at 0C. The mixture was stirred at 
room temperature overnight. The reaction was diluted with methylene chloride and 
washed successively with sat.NaHCO3 and brine. The organic layer was separated, dried 
over MgSO4, and filtered. The filtrate was concentrated. The residue was 
chromatographed on a column of silica gel eluted with 3:2 hexane/ethyl acetate to give 
compound 7 (275 mg, 45%). 
1
H NMR (300 MHz, CDCl3) δ ppm 3.03 (s, 3 H), 3.09 (s, 3 
H), 4.04 (s, 3 H), 5.52 (s, 2 H), 6.20 (d, J=3 Hz, 1 H), 6.93 (d, J=3 Hz, 1 H), 7.15-7.30 
(m, 3 H), 7.38 (d, J=7 Hz, 2 H), 8.47 (s, 1 H). 
13
C NMR (75 MHz, CDCl3) δ ppm 34.9,  
35.6,  40.7,  45.1, 100.7,  115.0,  126.6,  127.8,  128.0,  131.3,  139.0,  144.3,  154.1,  
156.1. ESI-MS (M+ H
+
) for C17H19N5O: expected 310.1662, found 310.1662. 
 
Compound 9. To a suspension of compound 7 (0.914 g, 2.95 mmol) and 1-(α, β)-O-
methyl-3,5-di-(O-p-toluoyl)-2ʹ-deoxy-D-ribose(compound 8) (1.36 g, 3.54 mmol) in a 
mixture of methylene chloride (12 mL) and acetonitrile (12 mL) was added a solution of 
SnCl4 in methylene chloride (1 M, 11.82 mL, 11.82 mmol). The reaction mixture was 





The reaction mixture was diluted with methylene chloride and washed successively with 
sat.NaHCO3 and brine. The organic layer was separated, dried over MgSO4, and filtered. 
The filtrate was concentrated. The residue was chromatographed on a column of silica gel 
eluted with 1:1 hexane/ethyl acetate to give compound 9 (0.840 g, 44 %). 
1
H NMR (300 
MHz, CDCl3) δ ppm 2.37-2.51 (m, 8 H), 3.01-3.07 (m, 3 H), 3.11 (s, 3 H), 3.99 (s, 3H), 
4.49-4.62 (m, 2 H), 4.65-4.74 (m, 1 H), 5.48-5.58 (m, 2 H), 5.75-5.81 (m, 1 H), 6.95 (s, 1 
H), 7.17-7.33 (m, 8 H), 7.39 (d, J=7 Hz, 2 H), 7.98 (dd, J=17, 8 Hz, 4 H), 8.56 (s, 1 H). 
13
C NMR (75 MHz, CDCl3) δ ppm 21.1, 34.4, 35.0, 37.5, 40.2, 44.5, 64.0, 72.9, 76.5, 
81.2, 112.6, 115.0, 126.1, 126.5, 127.0, 127.2, 128.5, 129.1, 129.6, 138.4, 141.7, 143.1, 
143.4, 153.4, 155.6, 156.0, 165.6, 165.8. ESI-MS (M+ H
+)
 for C38H39N5O6: expected 
661.2900, found 662.2919. 
 
Compound 10.  A suspension of 9 (0.430 g, 0.66 mmol) in 0.4 M potassium hydroxide 
in a mixture of ethanol and water (1:1, 10 ml) was heated under reflux overnight and 
allowed to cool to room temperature. The reaction mixture was evaporated to dryness. 
The residue was chromatographed on a column of silica gel with 5% methanol in ethyl 
acetate to give 10 (220 mg, 89%). 
1
H NMR (300 MHz, CD3OD) δ ppm 2.03 (dd, J=13, 6 
Hz, 1 H), 2.36-2.52 (m, 1 H), 3.62-3.71 (m, 1 H), 3.74-3.83 (m, 1 H), 3.93 (s, 3 H), 3.99 
(br, 1 H), 4.43 (d, J=5 Hz, 1 H), 5.20-5.32 (m, 3 H), 7.13-7.37 (m, 6 H). The 
1
H NMR in 
CDCl3 showed a different spectrum which indicates the formation of an intramolecular 
hydrogen bond between the benzyl C-H and the exocyclic amine. 
13
C NMR (75 MHz, 





133.1, 137.4, 144.2, 152.6, 156.6. ESI-MS (M+H
+
) for C19H24N4O4: expected 371.1714, 
found 371.1729. 
 
Compound 12. To compound 10 (304 mg, 0.82 mmol) and 10% palladium on carbon 
(600 mg) in ethanol was added ammonium formate (504 mg, 8 mmol) under Ar. The 
reaction mixture was heated under reflux overnight and then filtered through Celite. The 
filtrate was evaporated to dryness. The residue was chromatographed on a column of 
silica gel with 12% methanol in ethyl acetate to give 5 (106 mg, 46%). 
1
H NMR (300 
MHz, CD3OD) δ (ppm) 1.89- 2.02 (m, 2H), 2.35 (ddd, J=13, 11, 5 Hz, 1H), 3.60-3.68 (m, 
1H), 3.71-3.78 (m, 1H), 3.86 (s, 3H), 3.94 (d, J=1 Hz, 1 H), 4.04 (q, J=7 Hz, 1H), 4.38 
(d, J=5 Hz, 1H), 5.19 (dd, J=11, 5 Hz, 1H), 7.05 (s, 1 H). Compound 11 (144 mg, 0.54 
mmol) was co-evaporated with anhydrous pyridine (6 mL) three times and dried under 
vacuum overnight. It was then dissolved in pyridine (4 mL). TMSCl (0.7 mL, 5.4 mmol) 
was added slowly to the suspension in an ice bath. After 30 min, Isobutyric anhydride 
(0.45 ml, 2.7mmol) was added and the mixture was stirred for 2.5 h at room temperature. 
The reaction mixture was then chilled in an ice bath; 5 mL of cold water was added and 
the mixture was stirred for 15 min before con. aqueous ammonia (5 mL) was added. The 
reaction was stirred for another 30 min and the volatiles were the removed under reduced 
pressure. The residue was re-dissolved in dichloromethane and purified by column 
chromatography using 2% MeOH in ethyl acetate as the eluent to give 12 (111 mg, 58%). 
1
H NMR (300 MHz, CDCl3) δ ppm 1.16-1.32 (m, 6H), 1.16-1.21 (m, 2H), 2.02-2.13 (m, 
1H), 2.43-2.76 (m, 2H), 3.70-3.79 (m, 1H), 3.87-3.96 (m, 1H), 3.98-4.07 (m, 3H), 4.12 
(s, 1H), 4.60 (d, J=5 Hz, 1H), 5.27 (dd, J=11, 5 Hz, 1H), 6.97 (s, 1H). 
13





MHz, CDCl3) δ ppm 19.0,19.1, 35.7, 36.3, 36.3, 43.4, 64.1, 74.8, 75.6, 88.2, 114.6, 
116.5, 130.4, 140.8, 144.5, 153.2, 178.6. ESI-MS (M+H
+
) for C16H22N4O5: expected 
351.1663, found 351.1604. 
 
Compound 13. Compound 12 (104 mg, 0.3 mmol) was dried by coevaporation with 
anhydrous pyridine. The residue was suspended in anhydrous dichloromethane (6 mL), 
followed by the addition of dry triethylamine (80 µL, 0.6 mmol). A solution of 4, 4’-
dimethoxytrityl chloride (121 mg, 0.36 mmol) and DMAP (7 mg, 60 µmol) in 
dichloromethane was added and the reaction mixture was stirred at room temperature 
overnight before it was quenched by adding 0.1 mL MeOH. The reaction was diluted 
with dichloromethane and washed successively with sat.NaHCO3 and brine. The organic 
layer was dried over anhydrous MgSO4 and filtered. The solvent was removed in vacuo. 
The crude product was purified via flash silica gel column chromatography eluted with 
hexane/ethyl acetate/triethylamine (10%:88%:2%) to give the dimethoxytrityl ether of 13 
(123 mg, 60%) as a white foam. 
1
H NMR (300 MHz, CDCl3) δ ppm 0.84-1.03 (m, 3H), 
1.09-1.31 (m, 3H), 1.91-2.11 (m, 3H), 2.19 (dd, J=13, 5 Hz, 1H), 3.08-3.20 (m, 1H), 
3.23-3.40 (m, 2H), 3.72-3.82 (m, 6H), 3.99 (s, 3H), 4.04-4.17 (m, 1H), 4.58 (d, J=5 Hz, 
1H), 5.35 (dd, J=11, 5 Hz, 1H), 6.78 (dd, J=9, 4 Hz, 4H), 6.98 (s, 1H), 7.15-7.31 (m, 4H), 
7.34- 7.44 (m, 3H), 7.52 (d, J=7 Hz, 2H). 
13
C NMR (75 MHz, CDCl3) δ  ppm 18.6, 18.7, 
35.7, 36.1, 41.0, 55.2, 72.7, 74.7, 86.0, 113.1, 115.0, 115.9, 126.8, 127.8, 128.2, 130.1, 
130.4, 136.1, 136.4, 142.4, 143.9, 145.2,  153.5, 158.5, 178.2,  178.17. ESI-MS (M+Li
+
) 





Compound 14. A solution compound 13 (86 mg, 0.13 mmol), diisopropylethylamine (91 
µL, 0.52 mmol), and 2-cyanoethyl N,N’-diisopropylchloro phosphoramidite was stirred 
for 2 h at room temperature under argon. The reaction was quenched with 0.1 mL MeOH 
and concentrated in vacuo. The crude material was purified by silica gel chromatography 
using hexane/ethyl acetate (1:1) as the eluent to yield 14 (54 mg, 48%) as a white foam. 
1
H NMR (300 MHz, CDCl3) δ ppm 1.08 (d, J=7 Hz, 1H), 1.12-1.21 (m, 12H), 1.49 (d, 
J=7 Hz, 6H), 1.65 (s, 4H), 2.45 (t, J=7 Hz, 1H), 2.68 (d, J=7 Hz, 1H), 3.70 (d, J=7 Hz, 
1H), 3.77 (br, 9H), 4.02 (s, 4H), 4.05-4.17 (m, 4H), 6.78 (m, 4H), 7.03 (s, 1H), 7.16-7.30 
(m, 8H), 7.44 (s, 1H). 
31
P NMR (121 MHz, CDCl3) δ ppm 148.4, 149.0. ESI-MS (M+Li
+
) 
for C37H40N4O7Li: expected 859.4131, found 859.4237. 
 
2.4.1.1 DNA Synthesis and Purification 
Oligonucleotide 20 was purchased from Integrated DNA Technologies (Coralville, IA). 
Other oligonucleotides were synthesized on an ABI 394 DNA synthesizer. The 
phosphoramidites of Bz-A, dmf-G, Ac-C, T, 
7C
dG, and 5’-FAM were purchased from 







purchased from Berry and Associates, Inc. (Dexter, MI).
 
The coupling time of modified 
phosphoramidites was extended to 15 min. Oligonucleotides were deprotected in 
concentrated ammonia at 55 °C for 12 h. The crude oligonucleotides were purified by 
20% denaturing PAGE. The gel band that contained the desired oligonucleotide was cut, 
crushed, and soaked in a solution of 100 mM NaCl and 1 mM EDTA overnight. The 
extract was centrifuged and the supernatant was desalted using a C-18 Sep-Pak cartridge 





a Shimadzu UV-1700 spectrometer. High-resolution ESI-MS spectra of oligonucleotides 
were obtained in Rutgers University (Newark) mass facility after precipitation in 2.5 M 
ammonium acetate solution. 
 Oligonucleotide 18 (3'-TAC CCT GCA CGA CAX AGT TTC AGC GGC ATG-5'), 
calculated, 9198.5396 (M+H), found, 9198.7096; 
Oligonucleotide 16 (3’- ACT CTG TXC TTC GAT G-5’), calculated, 4871.8264 (M+H), 
found, 4875.9163; 
5’-Fam labeled oligonucleotide 22 (3’- TAC CTC TCT TCC XTC CTA CGA ATG C-
FAM-5’), calculated, 8072.7111 (M+Na), found, 8073.5228. 
 
2.5 Thermal Stability of Duplex DNA Containing N7-methyl-9-deaza-dG 
2.5.1 UV Melting Temperatures 
Duplex DNAs (50 μM for each strand) were hybridized in 100 mM  NaCl, 10 mM 
MgCl2, and 10 mM piperazine-N,N′-bis(2-ethanesulfonic acid) (PIPES) buffer  (pH 7.5). 
A solutions of the DNA duplex (1-5 μM) containing 20 mM NaCl, 2 mM MgCl2, and 10 
mM PIPES (pH 7.5) in a total volume of 100 μL was heated from 15 to 85°C at 1°C/min. 
UV absorbance at 260 nm was taken every 1°C. The melting temperatures were 
calculated from the first derivative of the curve using the LabSolution software. 
Experiments were performed in triplicate. ΔH and ΔS were derived from Van't Hoff plots 
using the equation 1/Tm = (R/ΔH)ln[C]total + (ΔS-Rln4)/ΔH. [C]total is the total 






2.5.2 Results and Discussion 
The melting temperatures of duplex DNA 15-16 were measured to study the impact of 
7Me9C
dG on the thermal stability of duplex DNA. The results showed that the duplex 
melting temperature (Tm) was lowered slightly by 1.3 °C in the presence of 
7M9C
dG when 
the duplex concentration was 5 μM. This small difference of Tm (
7M9C
dG) is unlikely to 
affects the polymerase fidelity significantly. Previous study by Verdine et al. on duplex 
DNA containing 
7Me
dG showed that 
7Me
dG also lowered melting temperature of duplex 
DNA.
53
 In that study, the melting temperature drop was mainly caused by the entropy 
effect. In fact, 
7Me
dG contributes to a stronger duplex in the enthalpy change. Study on 
duplex DNA containing 
7Me7C
dG, on the other hand by Seela et al. showed that 
7Me7C
dG 
contributes to a slightly weaker duplex in the enthalpy change.
69
 Replacement of dG with 
7Me7C
dG caused a decrease of 0-0.5 kcal/mol in ΔH per substitution, depending on the 
sequence.  
   To get a deeper understanding of thermal denaturation experiment, we obtained 
the thermodynamic parameters of the duplex formation (Table 2.1). The enthalpy change 
(ΔH°) of duplex formation was made significantly more favorable by the presence of 
7Me9C
dG. The base pairing stability of 
7Me9C
dG:dC showed an increase of  5.7 kcal/mol in 
enthalpy change. The different influences of base pairing of 
7Me7C
dG: dC and 
7Me9C
dG:dC 
on the enthalpy change of duplex formation could result from a variety of reasons. 
Structurally both bases contain a 7-methyl group and lack the N7 lone pair which is 
important for water binding. The 7-methyl group positively contributes to the stacking 
energy and should increase the stability of the duplex to a similar extent. However, The 
loss of the N7 binding site is expected to decrease the stability of the duplex,
70





amount of decrease should also be similar. Other differences between the two structures 
might be that the two base pairs may be different in hydrogen bonding energies or sugar 
ring conformations. The hydrogen bonding energy between 7,9-dimethyl-9-deazaguanine 
and 1-methylcytosine is 2.1 kcal/mol smaller than that between 7,9-dimethyl-7-
deazaguanine and 1-methylcytosine, according to a computational study conducted by 
our group. Therefore hydrogen bonding energy predicted a result opposite to the 
experimental observation. The other explanation based on sugar ring pucker is more 
reasonable due to the fact that C-nucleosides prefer the 3’-endo conformation, as opposed 
to the 2’-endo conformation expected for N-nucleosides.
64
  
           Despite the favored sugar ring conformation for duplex formation, the less 
favorable entropy change (ΔS°) contributed predominantly to destabilize duplex DNA. 




, although the impact of entropy change 
observed for 
7Me
dG was more dramatic. At room temperature, replacement of dG by 
7Me
dG resulted in an increase in duplex stability (-ΔG298), while replacement by 
7M9C
dG 












 Table 2.2 Thermodynamics of the Formation of Duplex DNA Containing 
7M9C
dG
a                                              
 
5’- TGA GAC ACG  AAG CTA C-3’ 
3’- ACT CTG  TXC  TTC  GAT G-5’ 
15, X = dG 





ΔH (kcal/mol) ΔS (cal/mol K) 
ΔG298 
(kcal/mol) 
15 61.1 -116.2 -322 -20.3 
16 58.8 -121.9 -345 -19.2 
a. Buffer conditions: 20 mM NaCl, 2 mM MgCl2, 10 mM PIPES (pH 7.5).  






REPLICATION OF N7-METHYL-9-DEAZA-DG AND 7-METHYL-7-DEAZA-DG 
BY KLENOW FRAGMENT (EXO
-
) OF E. COLI DNA POLYMERASE I.  
 
 
3.1 Background Information 
DNA is considered to be “the molecule of life” since it contains the genetic blueprint for 
all organisms. The ability to accurately and efficiently duplicate DNA is essential for the 
survival and proliferation of any organism. The process of replicating an organism’s 
genomic material is complex and requires the coordinated efforts of an ensemble of 
proteins to initiate, propagate, and terminate each biochemical event in a timely and 
orderly fashion.
71
 At the core of the replication process is the DNA polymerase, the 
enzyme that catalyzes the incorporation of mononucleotides into a growing polymer 
(primer) using a DNA template as a guide for directing each incorporation event. The 
newly-polymerized molecule is complementary to the template strand and identical to the 
template's original partner strand. During this process, the polymerase maintains an 
incredible degree of selectivity to insert only one of four potential deoxynucleoside 5′-
triphosphates (dNTPs) opposite a template base while possessing an extraordinary degree 
of flexibility to recognize four distinct pairing partners. DNA polymerases strictly follow 
the Watson-Crick base-pairing rules, with cytosine and guanine always forming a pair 
and thymine and adenine always forming a pair. The fidelity of a DNA polymerase is the 
result of accurate replication of a desired template. Specifically, this involves multiple 
steps, including the ability to read a template strand, select the appropriate nucleoside 





Crick base pairing is maintained. In addition to effective discrimination of correct versus 
incorrect nucleotide incorporation, some DNA polymerases possess a 3ʹ→5ʹ exonuclease 
activity. This activity, known as “proofreading”, is used to excise incorrectly 
incorporated mononucleotides that are then replaced with the correct nucleotide. The 
function of DNA polymerase is not quite perfect, with the enzyme making about one 
mistake for every billion base pairs copied, even with the assist of proof-reading ability.  
 
Figure 3.1 Cartoon depiction of DNA Polymerase Structure.  
 
The known DNA polymerases have highly conserved structures. The shape can be 
described as resembling a right hand with thumb, finger, and palm domains (Figure 3.1). 
The palm domain appears to function in catalyzing the transfer of phosphoryl groups in 
the phosphoryl transfer reaction. DNA is in the palm when the enzyme is active. The 





thumb domain plays a potential role in the processivity, translocation, and positioning of 
the DNA.
72
 DNA polymerase can add free nucleotides to only the 3ʹ end of the newly-
forming strand. This results in elongation of the new strand in a 5ʹ→3ʹ direction. No 
known DNA polymerase is able to begin a new chain (“de novo”); therefore replication 
requires a primer at which it can add the first nucleotide (Figure 3.2). The 3ʹ-OH group 
forms a bond to the phosphorous atom of the free nucleotide closet to the 5ʹ-O atom. A 
new phosphodiester bond now joins the two nucleotides. A pyrophosphate group (PPi) is 
 
 











liberated during the formation of the phosphodiester bond. The pyrophosphate is 
hydrolyzed, releasing a great deal of energy and driving the reaction forward to 
completion. Otherwise the pyrophosphate can inhibit the enzyme turnover.  
DNA polymerases are divided into seven families based on their sequence 
homology and crystal structure analysis. These include families A, B, C, D, X, Y and RT. 
Error-free (high-fidelity) lesion bypass and error-prone (low-fidelity) lesion bypass are 
important cellular responses to DNA damage during replication, both of which require a 
DNA polymerase. A high fidelity DNA polymerase, such as those in the A, B, and C 
families, has a very low error rate in incorporating correct nucleotides into the newly 
synthesized DNA strand. It follows the mechanism contributes to the selection of correct 
dNTP by Watson–Crick base pairing. While the low fidelity DNA polymerase, such as 
those in the X and Y families, incorporates non-Watson-Crick base-paired nucleotides 
into a growing DNA strand with relatively high frequency. High fidelity DNA synthesis 
is beneficial for maintaining genetic information. When a DNA lesion disallows a high-
fidelity polymerase to incorporate the correct nucleotide, replication stalls to avoid 
mutations. However, this may lead to cytotoxicity. In case of emergency, low-fidelity 
polymerases can be recruited to bypass the lesion, with a compromise of losing fidelity. 
In this work, DNA polymerase I (Pol I), a high-fidelity polymerase in prokaryotic 
cells, was used to examine the effects of the N7-methyl group of N7-Me-dG. DNA pol I 
obtained from E. coli is used extensively for molecular biology research. Discovered by 
Arthur Kornberg in 1956,
73
 pol I possesses following enzymatic activities : the 5'→3' 
(Polymerase) activity, and both the 3'→5' exonuclease (Proofreading) and the 5'→3' 





makes it unsuitable for many applications. Fortunately this undesirable enzymatic activity 
can be simply removed from the holoenzyme to leave a useful molecule called the 
Klenow fragment, widely used in molecular biology. The Klenow fragment is a large 
protein fragment produced when DNA polymerase I from E. coli. It retains the 5'→ 3' 
polymerase activity and the 3ʹ→5ʹ exonuclease activity for removal of precoding 
nucleotides and proofreading, but loses its 5'→ 3' exonuclease activity. Just as the 5' →3' 
exonuclease activity of DNA polymerase I from E.coli can be undesirable, the 3' → 5' 
exonuclease activity of Klenow fragment can also be undesirable for certain applications. 
This problem can be overcome by introducing mutations in the gene that encodes 
Klenow. These results in forms of the enzyme being expressed that retain 5' → 3' 
polymerase activity but lack any exonuclease activity (5' → 3' or 3' → 5'). This form of 




3.1.1 Mechanism of DNA Polymerization and Methods in the Measurement of DNA   
Polymerization Efficiency and Fidelity   
Kinetic mechanism for most DNA polymerases follows these steps (Figure 3.2). Step 1 is 
the binding of polymerase (E) to DNA substrate. Step 2 involves dNTP binding to the 
polymerase/DNA complex. Step 3 represents a conformational change in the polymerase: 
DNA complex that is followed by phosphoryl transfer (Step 4). After the nucleotide is 
covalently added to the growing primer, there is a conformational change step in the 
polymerase that relaxes the E′:DNAn+1:PPi to the E:DNAn+1:PPi species (Step 5). 
Following this step, PPi is released as the first product from the polymerase (Step 6). At 





synthesis on the same nucleic acid substrate or dissociate from the DNAn+1 to renew 
polymerization on another substrate. 
Maintaining fidelity during DNA replication is challenging since the changing 
nature of the heteropolymeric DNA template places strain on the unusually high demand 
for substrate specificity. The hydrogen bonding interactions explain how each 
incorporation event occurs efficiently and selectively.  The molecular events underlying  
 




reductions in misincorporation rates are typically interpreted with respect to perturbations 
in the formation of correct hydrogen bonds between the incoming dNTP and its 
mismatched partner. Simply put, the rates for misincorporating a dNTP are slow since the 
functional groups required for proper Watson-Crick interactions do not line up properly. 
Unfortunately, the nucleobases that provide favorable hydrogen bonding interactions are 





fidelity of DNA polymerases. Methylating agents such as MMS and MNNG 
preferentially react with the N3 and N7 positions of adenine and the O6 and N7 position 
of guanine.
2
 Methylation at the O6 position of guanine changes the hydrogen bonding 
capabilities, which increases the frequency of misincorporation events. In addition, 
methylation at the N7 position destabilizes the N-glycosidic bond leading to spontaneous 
depurination of this lesion and result abasic sites by nonenzymatically or via the actions 
of various DNA glycosylases (Discussed in next chapter). The abasic sites are strong 
blockers of high-fidelity DNA polymerases due to the lack of hydrogen-bond-forming 
nucleobases.   
It is well-established that a cancer cell is genetically different from its normal 
counterpart. Changes in genetic composition and context can occur by mutagenic events 
that are caused by inappropriate and/or dysfunctional DNA replication. To understand 
these mutagenic events, we need to examine how defects in DNA affect the activity and 
fidelity of polymerases, which contributes to the initiation and progression of cancer. A 
powerful approach toward understanding the mechanism of mutagenesis is to compare 
the catalytic efficiency of DNA polymerases for the incorporation of a correct (e.g., 
dGTP opposite cytosine) versus an incorrect (e.g., dGTP opposite thymine) nucleotide 
triphosphate. 
 In this chapter, the study of in-vitro mutagenesis on modified bases can be 
achieved from steady-state enzyme kinetic analyses. In these assays, a primer template 
complex is mixed with a polymerase and a dNTP. The primer is end-labeled with a 
fluorophore (5’-Fam). The reaction is run for a fixed amount of time (to keep the amount 





and dissociates from polymerase multiple times). The nucleotide insertion velocity (ν0) at 
the lesion site, given by the ratio of the integrated intensities of primers extended to the 
target site (and beyond) compared with the integrated intensity of primers extended to a 
site just prior to the target, was calculated for each [dNTP].  Velocities were calculated 
by using the equation
75
 ν0 = I/ (I0+0.5I) t , where I0 (DNAn) and I ( DNAn+1) ( Figure 
3.3a) are gel band intensities after t sec of reaction time. I is the amount of product 
formed, I0 is the amount of starting material. The maximum magnitude of I was 
controlled by adjusting the concentrations of dNTPs in the reactions and the reaction 
times. The velocity reflects the slowest step among polymerase association with primer-
template, substrate-initiated conformational change, formation of the phosphodieseter 
bond, dissociation of pyrophosphate, and dissociation and reassociation with a different 
primer-template. Treatment of the reaction with inorganic pyrophosphatase guarantees 
that pyrophosphate release is not the rate-determining step. The most likely rate 
determining step is the nucleotide incorporation step, particularly when mismatched 
nucleotide triphosphates are involved. The velocities for the incorporation of one 
nucleotide at a time vs dNTP concentration can be fit into the Michaelis-Menten equation 
(Equation 1).   
                 
                                  
The apparent steady-state kinetic parameters (Km and Vmax) for the incorporation of the 





then calculated by dividing the Vmax values with the concentration of the polymerase 
used. The efficiency of nucleotide incorporation was determined by the ratio of kcat/Km.   
 
                               
 
The fidelity of nucleotide incorporation fmis (misinsertion efficiency) was determined by 
the taking ratios of (Equation 3.2) incorrect to correct insertions i.e., the base normally 
pairing with the base that was modified (e.g. C with, N7-Me-G) for each of the four 





















(a)                                                                                     
    
(b)  
            
Figure 3.4 Polymerase assays. (a) PAGE analysis of Gel band intensity versus dNTP 
substrate concentration. The colors of the gel images were inversed for clarity. (b) 
Michaelis-Menten curves were obtained by using Origin 8.1.Reactions and product 
analyses were performed as described in 3.2"Polymerase Assays". All values are the 
averages of three independent experiments. 
 
 






DNA templates 17-19 (50 μM) were hybridized in equal molar ratio with the 5’-
Fam labeled primer in a solution of 12.5 mM NaCl and 12.5 mM Tris-HCl (pH 7.5). Kf 
(exo
-
) (New England Biolab, 0.320–20 nM) was incubated with inorganic 
pyrophosphatase (New England Biolab, 1.5 mole equiv.) in a 80 μL solution containing 1 
mg/mL BSA, 5 mM NaCl, 1 mM Tris-HCl, 1 mM MgCl2, and 100 nM DTT (pH 7.9) at 
25°C for 10 min. the enzyme solution was mixed with 80 μL of dNTP of different 
concentrations, which range from about 0.3Km to 3Km. After an appropriate amount of 
time (3-15 min, depending on the type of dNTP), the reaction were stopped by adding 40 
µL of 90% formamide loading buffer. The mixture was concentrated and loaded to 20% 
denaturing PAGE (Figure 3.4). 
The gel was visualized using AlphaImager
® 
EP with a liner dynamic range of 
4096 gray scale. The intensities of the primer and extension bands were quantified using 
Alphaview 3.0. When dTTP was used, multiple extension bands were observed. The total 
intensity of these bands was used for calculation. The reaction rates were calculated 
according to ν0 = I/(I0+0.5I)t. Michaelis-Menten curves were generated using values 
obtained from the averaging of at least three replicates using Origin 8.1 (Figure 3.4). 
 
3.3 Results and Discussion of Polymerase Assays 
Bypass of 
7Me9C




dG was studied in vitro. Single-nucleotide insertion experiments were performed 
using the standing start kinetic study of dNTP incorporation on a DNA template 




dG. In a crystal structure of Kf (exo
-
)/duplex DNA 





between the N7-position of guanine in the template. Hydrogen bonding plays crucial role 
in the process of DNA polymerization. The N7 nitrogen of dG is very different from all 
the N7-methyl compounds
61, 76-84
 due to its ability of bind water molecule or divalent 
metal ions.  Hence, we have used 
7C
dG instead of dG for comparison in order to 
separately investigate the influences of the additional methyl group and the loss of the N7 
binding site. We have performed single-nucleotide insertion experiments under steady-
state conditions and oligonucleotides 17-19 were used as the templates.  
 
        
Figure 3.5 A Crystal structure of Kf (exo
-
)/duplex DNA cocrystallized with ddCTP 
(PDB 2HVI). 
 







dG catalyzed by Klenow Fragment (Kf) (exo
-
) of E. coli DNA pol I 
were followed by PAGE. Initial rates were determined in reactions in which the extent of 
reaction was less than 30% completion.
79
 The kinetic parameters for all reactions are 





Replacing dG with the methyl did not significantly affect the binding of the DNA 
to the polymerase and the Km’s of dCTP incorporation opposite all three templates were 
similar. However, they were much higher than a typical Km of dCTP incorporation 
opposite dG (1-10 nM).
80 
We have observed the next higher Km of dTTP incorporation 
opposite all three templates, which may simply occur as a consequence of the geometric 







dG significantly  decreases the binding  






dG that differs from dG is their nonexistent hydrogen bond-accepting 
ability at N7, these results suggest that there may be an important major groove hydrogen 
bond to the N7 of dG during dCTP incorporation. The difference in Km indicates that the 
N7-position of guanine may be important for efficient dNTP binding. This result is 
consistent with the crystal structure of Kf (exo
-
)/duplex DNA cocrystallized with ddCTP, 
which shows a direct hydrogen bond between a water molecule and the N7 of dG 
opposite the ddCTP.
85
 The same water molecule is also hydrogen-bonded to the amide 
backbone of the protein. Thus, the loss the N7 lone pair disrupts the normal hydration in 
the polymerase binding pocket, which may be crucial in the conformational change 







dG with 2, 5 and 8-fold (Table 3.1) lower 
kcat than opposite dG, which indicates that the loss of the N7 lone pair slowed down the 
enzyme turnover slightly, whereas the size of the methyl group further amplified this 
effect. The catalytic efficiencies for Kf (exo
-





















) for unmodified dG 




dG confers a reduction in 
efficiency for dCTP insertion by approximately 2 and 3-fold, respectively. The major 
contributor to the reduction of catalytic efficiency is the weak binding resulting from the 
loss of the N7 lone pair. Overall, this result suggested that substitution of dG with the 
methyl group significantly slowed down polymerase replication; however, this catalytic 
efficiency reduction seems unlikely to induce the recruitment of low-fidelity polymerases 
in cells. The misinsertion frequencies (fmis) for dATP and dTTP opposite all three 
templates were similar. However, The misinsertion frequency for dGTP opposite 
7Me9C
dG 




dG. Overall, these three 
synthetic bases can be considered nonmutagenic for misinsertion events, because the 
misinsertion frequencies are still considered low compared to other known mutagenic 
DNA lesions. This result is consistent with other studies that support 7-methylguanine 























dG by Kf (Exo
-
) 




For the first time, the influence of the methyl group of 
7Me9C
dG on polymerase action was 
investigated by using chemically stable analogues. We found two important results. First, 
Template dNTP Km (μM) kcat (%.sec
-1
) 













  - 
1.152 ± 0.186 
294 ± 2.1 
170 ± 10 





dG dATP 308.1 ± 80.5 99 ± 13 0.32 2.1 x 10
-3 
7C








dG dCTP 1.180 ± 0.427 65 ± 8 55 1 
7Me9C












dG dCTP 0.562 ± 0.129 38 ± 2 68 1 
7Me7C















the Km of dCTP binding observed for all three templates were comparable (Table 3.1), 
but much higher than the typical dG template (in the low nM range). An apparent 
explanation is the loss of the metal-binding or hydration site provided by the N7 lone 
pair. This loss might have caused distorted structure of the polymerase-template-primer-
dNTP quaternary complex. The second important result is that the kcat of dNTP 
incorporation opposite 
7C




dG. This demonstrated that methyl group slowed down the turnover of the enzyme 
although it was originally expected to play minor roles in affecting polymerase actions. 
The fmis of the three templates were similar. They were about 2 orders of magnitude 
higher than a typical dG template, but still considered low compared to other DNA 
lesions. The methyl group itself does not cause significant misincorporation in high-
fidelity polymerases. It will also be important to expand these studies to additional 






STABILITIES OF THE GLYCOSIDIC BONDS OF N7-METHYL-9-DEAZA-DG- 
AND 7-METHYL-7-DEAZA-DG IN THE PRESENCE OF BASE EXCISION 
REPAIR (BER) ENZYMES 
 
4.1 Background Information 
Cellular DNA is susceptible to chemical modifications when exposed to a wide spectrum 
of exogenous and endogenous DNA damaging agents. These agents can lead to a wide 
variety of nucleobase modifications that can occur by oxidation or alkylation. Persistence 
of some of these DNA lesions can be mutagenic and/or cytotoxic. Genotoxicity and 
cytotoxicity cause altered gene expression and cellular apoptosis, leading to aging, 
cancer, and various neurological disorders. To combat the deleterious effects of DNA 
lesions, cells have a variety of DNA repair pathways responsible for restoring damaged 
DNA to its canonical form. Therefore studies of the mutagenicity of DNA lesions in vivo 
have to be conducted on the basis of understanding what repair systems might have been 
involved in attenuate the influence of the damage. On the other hand, unsuccessful repair 
results in missing base information or DNA strand breaks, which leads to the formation 
of secondary lesions.  In this chapter, we have examined the base excision repair (BER) 
pathway to confirm the stability of our modified nucleotide 
7Me9C
dG. The base excision 
repair pathway is a highly regulated network. The following are types of damages 
repaired by BER pathway: alkylated bases, oxidized bases, deaminated bases, bases with 
open rings, and AP sites.
1
 Incorporation of correct base in the BER pathway is essential 





breaks. The first enzyme to initiate the repair pathway is the DNA glycosylase, which is 
responsible for the excision of the damaged base. There are two kinds of DNA 
glycosylases; the monofunctional (MF) and the bifunctional (BF) DNA glycosylases. The 
MF glycosylases only have the glycosylase activity that enables them to excise the 
damaged base. They are hydrolase enzymes that simply use a water molecule to attack 
the anomeric carbon of the damaged nucleotide. The resulting abasic site can be 
efficiently excised in the base replacement segment of BER (Figure 4.1). The resulting 
single-stranded and nicked AP sites are processed by AP endonuclease 1 (APE1), which 
hydrolyzes the phosphodiester bond 5′ to the AP site. This generates a 3′ hydroxyl 
substrate for replacement synthesis by DNA polymerase β, followed by sealing of the 
resulting nick by DNA ligase complete the repair process. BF glycosylases differ from 
their MF counterparts by their using an active site amine nucleophile rather than water 
(Figure 4.1). This amine nucleophile also serves as a Schiff base electron sink to facilitate 
subsequent β elimination. β-Elimination of an AP site by a glycosylase-lyase yields a 3' 
α,β-unsaturated aldehyde adjacent to a 5' phosphate, which differs from the AP 
endonuclease cleavage product.
86 
Some glycosylase-lyases can further perform δ-
elimination, which converts the 3' aldehyde to a 3' phosphate. In addition, the BF DNA 
glycosylases possess the AP lyase activity, and thus they are capable of cutting the 
phosphodiester bond of the DNA, which creates the single strand break without the need 














In the BER pathway, the N-glycosyl bond of the damaged base is cleaved by a 
specific DNA glycosylase, releasing the damaged base. A wide variety of glycosylases 
have evolved to recognize different damaged bases and can be grouped into the different 
categories based on their substrates. To fulfill our motive to examine the stability of the 




dG against the actions of DNA glycosylase, we 
have used formamidopyrimidine DNA glycosylase (Fpg) and human alkyladenine DNA 
glycosylase (hAAG) because 
7C
dG is a known substrate of Fpg and 
7Me
dG is a known 
substrate of hAAG.
81, 82
 hAAG catalyzes the hydrolysis of the N-glycosidic bond to 
release the damaged base via MF repair pathway and generate AP site, whereas Fpg is a 
BF DNA glycosylase (N-glycosylase and AP-lyase). The N-glycosylase activity releases 
damaged purines from double stranded DNA, generating AP site. The AP-lyase activity 




5’-FAM labeled duplex DNAs (50 µM for each strand) were hybridized in 10 mM Tris-
HCl (pH 7.5) and 100 mM NaCl. A solution containing the DNA duplex (10 µM), 1 
mg/mL BSA, 1 mM bis-tris-propane-HCl (pH 7.0), 1 mM MgCl2, 1 μM DTT, and the 
enzyme (8 units) in a total volume of 10 μL was incubated at 37 ºC for 2 hours. For the 
Fpg reaction, 10 μL of 90% formamide loading buffer was added to stop the reaction. For 
the hAAG reactions, 1 μL of 3 M NaOH was added and the reaction was incubated for 
another 15 min before neutralized with acetic acid. Then 10 μL of 90% formamide 





cooled on ice. The samples were analyzed by 20% denaturing PAGE. The gel was 
visualized using AlphaImager
® 
EP. The intensities of the bands were quantified using 
Alphaview 3.0. 
 
4.3 Results and Discussion of Glycosylase Assays 




dG against the actions of Fpg 







dG (23) were incubated with 1.67 μM (8 units in 10 μL) Fpg for 2 hours 
(Figure 4.2a). Faster moving bands in the gel corresponded to the cleaved single-stranded 
DNA generated via the AP lyase reactions and the deglycosylasation reactions catalyzed 
by Fpg. Quantification of the bands showed that Fpg cleaved over 95% of the duplex 
containing 
7C
dG while we observed 10% cleavage of the duplex containing 
7Me7C
dG. The 
kcat of the cleavage of 7-deazaguanine is estimated to be 0.005 min
-1
, based on the fact 
that the duplex DNA concentration (10 μM) used in this study was much higher than the 
typical Km of an Fpg substrate. The duplex containing 
7Me9C
dG was stable and remained 
intact after 2 hours of incubation. 
The same experiment was repeated for duplex DNAs containing 2’-deoxyinosine 
(dI, 20), 
7Me9C
dG (21), and 
7Me7C
dG (22) with 67 nM (8 units in 10 μL) of hAAG for 2 
hours (Figure 4.2b). hAAG does not have the AP lyase activity and thus the reaction was 
further incubated with 0.3 M NaOH for 15 min to facilitate the cleavage of the AP site. 
The base treatment was expected to generate a β-elimination product as well as a δ-
elimination product. The total amount of cleavage of the duplex containing the dI:dC 





lanes 11 and 12. To confirm that these bands were in fact caused by NaOH, we extended 
the incubation time of 23 solely with NaOH to 18 h. We have observed that the percent 
cleavage was increased to 55%. To further confirm the hAAG action in lane 12, we 
extended the incubation time of 23 with hAAG to 18 hours and doubled the amount of 
enzyme while maintaining the NaOH incubation time of 15 min. We have observed only 
weak cleaved bands (Figure 4.3). Surprisingly, 
7Me9C
dG did not show any sign of 
cleavage, whether with NaOH alone or with hAAG followed by NaOH treatment. These 
results demonstrated that 
7Me9C
dG was remained intact in the presence of  hAAG whereas 
hAAG is likely to cut 
7Me7C
dG due to the broad substrate specificity (see later 
discussions) would be at very low rate.  
As a DNA glycosylase with broad substrate specificity, Fpg was previously 
reported to remove N7-methyl-8-oxoguanine with much lower activity compared to the 
removal of 8-oxoguanine (OG).
5
 The OG result in fact can help to explain that Fpg also 
removed 
7Me7C
dG but with much lower activity than 
7C
dG. The hydrogen bond between 
the backbone oxygen of a serine residue and the N7H of OG is responsible for the 
selectivity of Fpg for OG over undamaged guanine.
88
 A similar CH-N hydrogen bond can 
possibly form between the serine residue and the C7-H of 
7C
dG and when a methyl group 
is added to the N7 position of OG or the C7 position of 
7C
dG, the enzyme activity is 









5’- ATG GAG AGA AGG CAG GAT GCT ATC G-3’ 
3’- TAC CTC TCT TCC XTC CTA CGA ATG C-FAM-5’ 




      22, X = 
7Me9C
dG 




Figure 4.2 PAGE analysis of cleavage of duplex DNA containing damaged Nucleobases 
or Nucleobase Analogues.  (a) Incubation with Fpg. Lane 1 and 2, substrate 21; lane 3 
and 4, substrate 22; lane 5 and 6, substrate 23. Conditions of lane 1, 3, and 5: 10 µM 
duplex, 1 mg/mL BSA, 1 mM bis-tris-propane-HCl (pH 7), 1 mM MgCl2, 1 μM DTT, 
37C, 2 h; Conditions of lane 2, 4, and 6: same as lane 1, 3, and 5 except that Fpg (1.67 
μM) was added. (b) Incubation with hAAG. Lane 7 and 8, substrate 20; lane 9 and 10, 
substrate 22; lane 11 and 12, substrate 23.  Conditions of lane 7, 9, and 11: 10 µM 
duplex, 1 mg/mL BSA, 2 mM tris-HCl (pH 8.8), 1 mM (NH4)2SO4, 1 mM KCl, 200 μM 
MgSO4, 37C, 2h,  then 0.3 M NaOH, 37C, 15 min. Conditions of lane 8, 10, and 12: 
same as lane 7, 9, and 11 except that hAAG (62 nM) was added. 
 
 
Human AAG, excises a variety of substrates including alkylated purines and 
hypoxanthine (Hx), the deamination product of adenine. hAAG also act on undamaged 
purines but the activities of hAAG on dI and alkylated purine nucleosides are 
significantly higher.
89
  In our experiment, we extended the reaction time for 
7Me7C
dG to 
18h and doubled the enzyme concentration. However, the results showed no obvious 






                                                              1                   2 
                                                     
Figure 4.3 Incubation of duplex DNA 23 with NaOH. Conditions of lane 1, 2: 10 µM 
duplex. Lane 1, in 0.3 M NaOH, 37C, 18 h. Lane 2, in  124 nM hAAG, 1 mg/mL BSA, 
2 mM tris-HCl (pH 8.8), 1 mM (NH4)2SO4, 1 mM KCl, and 200 μM MgSO4, 37C, 18h,  




hAAG may still cut 
7Me7C
G at an extremely slow rate, which is similar to the 
cleavage of undamaged purines.  Although, the exact kcat cannot be measured under our 




 if the amount of 
cleavage after 18 h is considered less than 0.5%. This slow rate of cleavage should not 
affect normal cellular studies.  
 




dG was stable against both enzymes, which opens up the possibilities that it can be 
an inhibitor of BER enzymes. Since many anticancer drugs act by damaging DNA, 
thereby arresting cells in the act of DNA replication. Thus, in this context, DNA repair is 
undesirable and drugs that block repair of drug-induced lesions may synergistically 
enhance the chemotherapeutic effect of some anticancer drugs. In this kind of therapy, an 





cleaved by them may serve as an inhibitor. By keeping this in our mind, we have 
investigated the role of 
7Me9C
dG as an inhibitor for hAAG. The hAAG assay for dI 
cleavage was repeated in the presence of 22 in various concentrations (1-5 µM) to check 
the inhibition effect of 
7Me9C
dG. Percent inhibition of the enzyme activity was plotted 
against the inhibitor concentrations. The result showed only a small effect of inhibition, 
around 75% inhibition was observed at 5 μM of 22 (Figure 4.4). The inhibition constant 
(Ki) was estimated to be around 75 nM based on the reported Km on a dI substrate.
82,89
  
                     
Figure 4.4 Inhibition of hAAG on a dI Substrate by duplex DNA containing 
7Me9C
dG. 
The experiments were performed in triplicates. 
 
4.5 Conclusion 




dG in the presence of BER enzymes 
Fpg and hAAG. A difficulty to study the biological effects of N7-methyl-dG adducts in 
cells is due to their low stabilities. In contrast to the in vitro conditions where N7-methyl-
dG can survive through a reasonable amount of time at ambient temperature and pH 





the N7-methylated bases quickly. The advantage of using a stable analogue of N7-
methyl-dG is not only to generate a single adduct through oligonucleotide synthesis, but 
ensure that the chemical structure of interest remains intact if additional studies are to be 
carried out in cells. Our studies showed that the glycosydic bond of 
7Me7C
dG 7 was cut by 
Fpg at the kcat of 0.005 min
-1







), the cleavage will be significant if a study is to be carried out in 
cells and last 1-2 days. 7-Me-7-deaza-dG was stable in the presence of hAAG for at least 
18 h. Obviously, the reaction catalyzed by hAAG is slow, it is prudent to avoid the 
structure of 
7Me7C
dG if cellular studies are necessary. In contrast, its analogue 
7Me9C
dG 
was stable against both enzymes. Therefore, 
7Me9C
dG is a more versatile analogue of N7-
Me-dG than 
7Me9C
dG, especially when in vivo study is needed. Inhibition studies of 
hAAG on a dI substrate in the presence of duplex DNA containing 
7Me9C
dG demonstrated 
that hAAG binds the inhibitor with a similar affinity to its substrate. This study has 
generated a hypothesis that can guide future experimental and theoretical studies directed 






DESIGN AND SYNTHESIS OF DNA METHYL TRANSFERASE INHIBITORS 
 
 
                                                           5.1 Introduction 
5.1.1 DNA Methylation 
DNA methylation is a crucial biochemical reaction responsible for epigenetic regulation, 
which greatly influences gene activation, chromatin stability, and so on.  
 
         
 
Figure 5.1 Methylation of cytosine catalyzed by DNMTs.  






In mammals, normal DNA methylation is controlled by DNA methyltransferase 
(DNMT), an enzyme that catalyzes the transfer of a methyl group from S-adenosyl-l-
methionine (SAM) to the C5-postion of cytosine (Figure 5.1). SAM is a common 
cofactor in cells. The methyl group attached to the cationic sulfur atom in SAM is 
chemically reactive. This allows donation of this active methyl group from the sulfur 
center to a specific position in a variety of substrates, e.g., DNA, RNA, proteins, and 
secondary metabolites catalyzed by methyltransferases (MTs). More than 
40 metabolic reactions share this mechanism, and the product is S-adenosyl 
homocysteine (SAH) (Figure 5.1), which is an inhibitor of the most methylases.  
 
5.1.2 The Catalytic Mechanism of DNA Methylation 
The catalytic mechanism of DNA cytosine-C5 methylation
90
 is shown as Figure 5.2. 
DNMT forms a complex with DNA, and the cytosine to be methylated flips out from the 
DNA. The thiol group of a cysteine residue in the active site of DNMTs serves as a 
nucleophile that attacks the 6-position of the target cytosine to generate a covalent 
intermediate. The 5-position of the cytosine is activated and conducts a nucleophilic 
attack on the SAM to form the 5-methyl covalent adduct and SAH. The attack on the 6-
position is assisted by a transient protonation of the cytosine ring at the endocyclic 
nitrogen atom N3. The proton is provided by a nearby a glutamic acid residue. The same 
Glu residue is also in contact with the exocyclic N4 amino group.  The extremely electron 
negative O-2 may also be stabilized by an arginine residue. Following the methyl 
transfer, the deprotonation at the 5-position generates elimination products: the 





elimination does not occur and the enzyme becomes permanently bound to DNA. That is 














Figure 5.2 The proposed mechanism of DNA cytosine-C5 methylation. 
 
5.1.3 Biological Importance of DNA Methylatransferase (DNMT) 
All the known DNA methyltransferases use SAM as the methyl donor. There are four 
different DNMTs known in mammals: DNMT1, DNMT3a, DNMT3b and DNMT3L. 
DNMT1 (DNA cytosine-5-methyltransferase1) is responsible for the maintenance of 
methylated DNA by copying DNA methylation patterns from the parental strand to the 





ubiquitous; it is highly expressed in fetal tissues, heart, kidney, placenta, peripheral blood 
mononuclear cells, and less expressed in spleen, lung, brain, small intestine, colon, liver, 
and skeletal muscle.
91, 92
 Differently, de novo methyltransferase DNMT3A is only present 
in low amounts in somatic cells and shows no preference for hemi- or unmethylated 
DNA.
93
 It is widely accepted that DNMTs play a causal role in cancer formation through 
their DNA methylation activity on tumor suppressor genes, which makes them suitable 




5.2 Developed DNMT Inhibitors 
DNMT inhibitors (DNMTi) can be classified into two broad categories. One category 
includes nucleosides inhibitors, which are incorporated into DNA and act as suicide 
inhibitors via a covalent adduct formation. The second category is the non-nucleoside 
inhibitors.
95
 To date, only two nucleoside analogs, 5-azacytidine (Vidaza) and 5-aza-2’-
deoxycytidine (also known as Decitabine, Dacogen), have been used clinically. These 
drugs, after incorporation into DNA, cause covalent trapping and subsequent depletion of 
DNMTs. Azacitidine and Decitabine are approved by the FDA for the treatment of 
myelodysplastic syndrome.
96
 These 5-azanucleoside analogues can be incorporated into 
DNA to replace cytosine. The absence of a hydrogen atom at the C5 position hinders 
DNMT release by β–elimination, with the consequence of DNMT trapping and     
degradation (Figure 5.4).  Because of the nitrogen substituted base forms a stable 






Figure 5.3 Nucleoside DNMTi. 
 
the demand for more effective and selective DNMTi. Zebularine (Figure 5.3) is a novel 
DNMT inhibiting drug which offers much promise due to low toxicity, stability and 
effective bioavailability when administered orally. It also has high selectivity for tumor 
cells. The downfall of this drug has been the requirement for high doses (1 g/kg in 
mouse) which may pose problems in clinical trials.
97
  
To avoid the toxicity and stability problems associated with nucleoside DNMTi, 
efforts have focused on the development of non-nucleoside reversible inhibitors. 
Generally, they inhibit DNA methylation by binding directly to DNMTs without 
incorporation into DNA. Some of the reversible DNMTi’s (Figure 5.5a) are approved 
drugs for other indications, e.g., the anti-hypertensive drug Hydralazine, the local 
anesthetic Procaine, the anti-arrhythmic drug Procainamide,
98
 and the methylene 
disalicylic acid NSC14778
99
 (Figure 5.5b). Some DNMT inhibitors have been identified 
by docking-based virtual screening. Examples include the L-tryptophan derivative 
RG108 (Figure 5.5b), RG108 (NSC401077) was first characterized by Brueckner et al.
100
 
in 2005 and was conceived to interact with the catalytic domain of DNMT1.
101 
This 





not been disclosed yet) can safely and effectively lead to reactivation of methylation 
silence tumor suppressor genes. This has been shown in patients with RCC, a disease 
associated with hypermethylation and silencing of cell growth control and tumor 
suppressor genes.
102 
MG98 seemed promising and was used in a Phase I study in solid 
tumors.
103
 Because of current preclinical and clinical evidence, further phase II 
development of MG98 would be of interest. Recently, a non-nucleoside inhibitor, SGI-



























Unlike genetic changes, epigenetic changes can be modified by the environment, 





can modulate the DNMT enzyme activities and thus promoter methylation pattern of 
genes in cancer. Apigenin in Parsley (Petroselinum), curcumin (1,7-bis (4-hydroxy- 3-
methoxyphenyl)-1,6-heptadiene-3,5-dione) in turmeric (Curcuma longa), EGCG in green 
tea (Camellia sinensis), genistein in soybean (Glycine max), resveratrol (3,40,5-
trihydroxytrans- stilbene) in red grapes (Vitis vinifera), sulforaphane (SFN) in 
cruciferous vegetables (Brassicacaae), and the caffeic acid and chlorogenic acid as  




SAH can bind to DNMTs and inhibit their catalytic reaction and has an important 
role in the regulation of biological DNA methylation. SAH analogs presumably binding 
in the co-factor binding pocket have also been reported as selective inhibitors against 
DNMT1 over DNMT3b2 by using rational design approach.
108 
According to previous 
data (Figure 5.5 d (a)), replacement of the homocysteine side chain by the five membered 
(2S,4S)-4-mercaptopyrrolidine-2-carboxylic acid was a good replacement, while the 
corresponding six-membered counterpart was less active. It was also found that deletion 
of the carboxylic group (Figure 5.5 d (d)) eliminating the zwitter-ionic character was less 
active against enzymes. In addition, another SAH analogue (Figure 5.5e), which contains 
a shorter carboxyl side chain, was reported
109
 to be a strong inhibitor for DNMTs, 









                                                             
Figure 5.5 Chemical structures of non nucleoside DNMT inhibitors and other selected 
compounds with proposed demethylating activity. (a) Drugs used for other indications, 
(b) Compounds identified using virtual screening, (c) SGI-1027 and its analogue
105
 (d) 











5.3 Crystal Structure Study and Design Concept for DNMTi 
SAH is a known strong inhibitor of DNA methyltransferases at the SAM binding site, 
although the biological roles of SAH on the inhibition of DNMTs are not completely 
understood. Furthermore, SAH-binding proteins are widely found in cells and it is 
unlikely to use SAH to selectively inhibit DNMTs. The ideal inhibition should fill the 
following requirements. First, they can specifically inhibit cytosine DNA 
methyltransferases vs. other methyltransferases, and second, as mentioned earlier, they 
should bind DNMTs reversibly. The crystallographic structure of human DNMT1 is a 
very important tool to guide the design. There is more than one binding site within 
DNMT1. The one for SAM and the one for the extra helical cytosine of the duplex DNA 
are close to each other. It can be expected that an SAH analogue that occupies both 
pockets at the same time would selectively bind DNMTs. However, there is a concern 
whether this SAH analogue would bind differently in the absence of the DNA, as a study 
on a prokaryotic DNMT suggested that binding of SAM occurred after DNA binding, 
therefore it is likely that the SAM binding pocket is shaped through DNA binding. A 
superposition study of a bound SAH in DNA-free mDNMT1 and the productive covalent 
mDNMT1-DNA complex was performed by Wu
111
 to evaluate the significance of the 
change. The results showed that SAH undergoes a slight positional shift from the DNA-
free state to its productive covalent complex with DNA. Although the overall structural 
change is so small that the SAH analogue would bind the protein in its active 








   
Figure 5.6 Interactions between SAH mDNMT1-DNA complex. Left: Interactions 
between SAH and binding pocket residues in free mDNMT1. Right: Bound SAH in the 
productive covalent mDNMT1-DNA complex is stabilized. Hydrogen bonds: black 
dashed lines; hydrophobic interactions: green dashed lines.
 112
                                              
 
 
The crystal structure of SAH and human DNMT1-DNA complex (figure 5.7) 
provided additional detailed information on the relative geometric locations of these two 
binding sites. The flipped out cytosine adopts an extra helical position to insert into a 
cytosine binding site that is in close proximity to the sulfur of SAH (Figure 5.7). The 
distance between the carbon at 5 position of cytosine and the sulfur atom of SAH is 4.5 
Å. The flipped-out cytosine was stabilized by surrounding residues in the active site of 
the enzyme. (Figure 5.8) The carbonyl of the cytosine forms two hydrogen bonds with 
Arg 1313 and Arg 1315, and the 3-nitrogen forms a hydrogen bond with Glu 1269. The 
4-amino group forms a hydrogen bond with the backbone of Pro 1227. This result 





of cytosine may play vital roles in binding. The 3-nitrogen may be less important when 
Glu1269 is deprotonated.  
                                
Figure 5.7 The crystal structure of SAH and human DNMT1-DNA complex (PDB: 
4DA4). SAH1701 in chain A, Cytosine4918 in chain D, and parts of the DNA sequences 




                                           
 













Figure 5.8 The flipped-out cytosine is stabilized by surrounding residues in the active 







A transition state analogue was designed to occupy the SAM binding site and the 
cytosine binding site simultaneously. It was decided that part of the SAM core structure 
was to be kept and part to be deleted. First, adenosine and the long chain should be kept. 
As Figure 5.6 shows, SAH can form several hydrogen bonds with the amino acid residues 
at the binding site of DNMT1, such as Glu 1171, Met 1172, Leu 1154, Val 1582, Gly 
1153.  Therefore, to maintain these interactions between DNMT1 and SAM analogues, 
the adenosine and carboxyl group with the long chain should be kept. Second, to be a 
selective inhibitor, extra binding interactions other than the ones involving SAH are 
required. The process of DNA cytosine methylation involves the addition of a methyl 
group to cytosine at the C5 position. Therefore, introducing a cytosine to the SAM 
analogue may enhance binding by taking advantages of the interactions between cytosine 
and cytosine-binding side chains. To simplify the synthesis, it was decided to use other 
functionalized aromatic rings (benzene or heterocyclic rings) to replace cytosine. Third, 
the sulfur atom with positive charge can be changed to a nitrogen atom, which is 
expected to be protonated under physiological conditions. Fourth, the α-amino group of 
SAM can be removed because it is not involved in any interaction with the protein, and it 
may affect the protonation state of the adjacent tertiary amine.  
                                        





 In summary, the design of SAM analogues was inspired by the catalytic 
mechanism of DNMT and the study of the crystal structure of DNMT/DNA/SAH 
complex. The distance between the branching nitrogen and the aromatic ring is set to be 2 
C-C bond-long to reflect the distance during the methyl transfer in the catalytic 
mechanism. A series of compounds were designed that contained different aromatic 
derivatives. These derivatives were expected to interact with the amino acid side chains 
mimicking the flipped cytosine in the catalytic mechanism. Among these compounds, 24 
was previously prepared by Wu.
111 
The preparation of 25 and 26 is described below. 
 
5.4 Synthesis of DNMT Inhibitors 
5.4.1 Retrosynthetic Analysis 
 
 






Compound 24-26 can be generated from three parts according to our 
retrosynthetic analysis (Scheme 5.1): the phenylacetaldehydes (33, 34), methyl 4-
oxobutanoate, and 5’-amine-modified adenosine 31. The three parts will be joined 




Scheme 5.2 General Synthesis Route. (a) NaBH3CN, AcOH, (b) p-TsOH.H2O (2equiv.), 
MeOH, (c) KOH. 
 
 
The general synthetic strategy after the first reductive amination reaction is shown 
in scheme 5.2. In the case of the synthesis of 25, the O-Bn group was removed by 





via acid-catalysis methanolysis. The methyl esters were hydrolyzed under strong alkaline 
conditions.  
 
5.4.2 Synthesis of the Common Precursor 31 
The synthesis started from commercially available adenosine. The 2ʹ-and 3ʹ-hydroxyl 
groups were protected using acetonide. The reaction initially finished in nearly 60% 
yield. The reaction conditions included 11 mol equivalents of p-toluenesulfonic acid (p-
TsOH) and a large excess of acetone, which was both a reactant and a solvent. The 
product was isolated by organic extraction. Several conditions have been examined to 
improve the reaction yields. We changed the amount of p-TsOH to 4.3 mol equivalents 
and decreased the solvent volume by 10 folds (Scheme 5.3). This change increased the 
acid catalyst concentration although the total amount of catalyst became less. In addition, 
extremely dry acetone was successfully prepared by fractional distillation over Drierite®. 
Potassium carbonate pellets were added directly to the reaction mixture to neutralize p-
TsOH. This workup procedure avoided aqueous conditions which could convert some of 
the product back to the starting material due to the slow neutralization process. The yield 
was improved to 93% yield, higher than reported in most literatures.
113, 114
 After the 
acetonide was installed, a leaving group was introduced by transforming the free 5ʹ-
hydroxy group of the 2ʹ, 3ʹ-O-isopropylideneadenosine (27) into a mesylate ester (28) 
using MsCl (Methanesulfonyl chloride) in the presence of triethylamine (TEA). 
Increasing mol. equivalence of MsCl from 1.2 to 1.6 and lowering solvent volume by 9 
fold improved product yield. Compound 28 was very unstable and it was initially directly 
converted to an azide by adding sodium azide to the crude product in DMF without 





silica gel chromatography gave high recovery and the subsequent reaction with azide 
could be completed in much improved yield. Reduction of compound 29 was achieved by 
hydrogenolysis on Pd/C at 50 psi, which gave 5ʹ-aminoadenosine derivative 30 
 
 
Scheme 5.3 Synthesis of Compound 31 (a) Acetone, p-TsOH, rt, 2 h, 93%. (b) CH2Cl2, 
EtN3, MsCl, rt, 1.5 h, 89%. (c) NaN3, DMF, 70°C, 48 h, 60%. (d) H2, 10% Pd/C, MeOH, 
50 psi, 16 h, 70%. (e) NaBH3CN, AcOH, methyl-4-oxobutanoate, rt, 1.5 h, 12%. 
 
Reductive amination of compound 30 with methyl 4-oxobutanoate was hard to 
control. As a result, disubstituted byproduct was formed: the mono- and di-substituted 
products could not be completely separated (Scheme 5.4.). Reducing the amount of 
methyl 4-oxobutanoate by 3 folds gave better selectivity, however, with a comprised low 








Scheme 5.4 Reductive Amination of Compound 30. 
 
5.4.3 Synthesis of 2-(o-Benzyloxy)phenylacetaldehyde (33) 
The benzyl protected 2-(o-benzyloxy)phenylacetaldehyde can be synthesized from the 
commercially available 2-(o-hydroxyphenyl)ethanol. First, the 2-hydroxyl group was 
protected with a benzyl group (scheme 5.5) to prevent oxidation in next step. The next 
step is the oxidation of (2-(o-benzyloxyphenyl)ethanol.  IBX (2-iodoxybenzoic acid ) was 






                
 
Scheme 5.5 Synthesis of 2-(o-Benzyloxy)phenylacetaldehyde (33) (a) K2CO3,BnBr, 
DMF, 60°C, 16 h, 52%. (b) IBX, THF, 60°C, 16 h, 33%.                        
                           
5.4.4  Synthesis of Compound 25 
Compound 33 was reacted with 31 via reductive amination and the product 36 was 
purified by column chromatography (Scheme 5.6). The product formation was confirmed 
by Mass analysis (Figure 5.10a). The benzyl group was removed by hydrogenolysis. The 
product was subjected to acid methanolysis to remove the acetonide (Scheme 5.7). The 
product was used directly for next base hydrolysis reaction. After base hydrolysis, the 
final compound 25 was obtained. The yield of compound 25 was too low for column 
chromatography purification. Therefore, it was purified by HPLC and the collected 





Scheme 5.6 Synthesis of Methyl Ester Compound 36. 
 
 
Scheme 5.7 Synthesis of Compound 25. (a) H2, 10% Pd/C, MeOH, 50 psi, 4 h (b) 0.2M 






Figure 5.10a Mass Spectra of Compound 36. (Bottom: ESI-MS (M+H
+
) for C33H40N6O6, 











                               
Figure 5.11 Cyclohexanone Derivative of Compound 25 
 
However, the Mass spectrum of the expected fraction showed a molecular ion 
with higher m/z than expected: ESI-MS (M+H
+
) for C22H29N6O6, expected 473.2065, 
Observed  ESI-MS (M+H
+
) 475.3316(C22H31N6O6) (Figure 6.1b). One possible 





hydrogenolysis conditions and the cyclohexanone derivative of compound 25 was 
generated (Figure 5.11). 
 
5.4.5 Synthesis of 4-Nitrophenylacetaldehyde (34) 
Compound 34 needs to be synthesized by oxidation from 4-nitrophenylethanol.  PCC 
oxidation was tried at the beginning. To our surprise, 
1
H NMR study of the product 
showed that despite the presence of the aldehyde peak, the expected CH2 peak was 
missing at around 3-4 ppm (Figure 5.12).  The spectrum agreed with the formation of 4-
nitrobenzaldehyde (Scheme 5.8 (a)), which implied that this oxidation condition was too 
strong. The C-C bond of the possibly formed 4-nitrophenylacetaldehyde was cleaved in 
such conditions. Later, we decided to tried milder oxidation reaction. Neither Swern 
oxidation nor TEMPO-NaClO oxidation gave the desired product. Therefore DMP was 
selected as the oxidant.  
We planned to use DMP (Dess–Martin periodinane) because DMP is mainly used 
as an oxidant for complex, sensitive and multifunctional alcohols. According to reported 
procedure, we synthesized DMP from IBX (2-iodoxybenzoic acid) and acetic 
anhydride.
54, 115
 The product was directly precipitated from the reaction mixture when the 
temperature was cooled to room temperature. The resulting white solid was not soluble in 
methylene chloride, suggesting that DMP was not completely formed and the precipitate 
contained a large amount of IBX. Reaction with this self-prepared DMP proceeded but 
generated poor yields even with extended time. Later we used pure IBX to replace DMP 
and increased the temperature for the reaction and obtained final compound 34 in 34% 









              
            
 











H NMR Spectrum of 4-nitrobenzaldehyde.           
           







5.4.6 Synthesis of Compound 26 
During the synthesis of 36, we found through NMR study that methyl 4-oxobutanoate 
was oxidizing slowly in air, which could impact the yield and the purity of the reductive 
amination product. Methyl 4-oxobutanoate is expensive and it is unlikely to purchase a 
new batch for each reaction. Therefore we have decided to prepare the material in our 
lab. Ethyl 4-bromobutyrate was identified as the commercial precursor to ethyl 4-
oxobutanoate. Several efforts were made to realize this transformation. The first attempt 
was the direct oxidation of the alkyl bromide to generate the aliphatic aldehyde. 
Oxidation of alkyl halides with pyridine N-oxide has been known as a unique method to 
obtain carbonyl compounds.
117
 N-oxide is the oxidized product of a tertiary amine, which 
finds wider application as an oxidants.
118
  It can be prepared using a variety of oxidants 
including m-chloroperoxybenzoic acid (mCPBA) and hydrogen peroxide.  
Accordingly, 4-dimethylaminopyridine N-oxide (DMAP N-oxide) was 
synthesized using m-CPBA.
119
 IR spectrum showed complete conversion to DMAP N-
Oxide. The resulting DMAP N-Oxide was used directly for the oxidation of ethyl 4-
bromobutyrate (Scheme 5.9 (a)). However, crude NMR of the reaction showed no peak at 
around 9-10 ppm, indicating no aldehyde product was formed. It was also reported
120
 that 
oxidation of primary, secondary, and tertiary amines with basic permanganate and rapid 
isolation of the reaction products result in an advantageous method for degrading amines 
to aldehydes and ketones. Accordantly, we tested the reaction using ethyl 4-
aminobutyrate hydrochloride as a staring material to synthesize ethyl 4-oxobutanoate 
(Scheme 5.9 (b)).
121
 Unfortunately, this reaction did not afford the desired product either. 





pyridine N-Oxide (Scheme 5.9 (c)). The reaction was completed in 16 h and purified by 
column chromatography, giving ethyl 4-oxobutanoate in 9.6% yield. This low yield 
became a problem for the next steps when the synthesis was scaled up.                                          
 
              
Scheme 5.9 Synthesis of Ethyl 4-Oxobutanoate. 
 
Compound 30 was reacted with ethyl 4-oxobutanoate via reductive amination 
(Scheme 5.10). However, even with this freshly-made highly pure aldehyde, we still 
could not improve the yield. This suggests that the selectivity of N-alkylation of primary 
amine is inherently difficult to control. Later, we have changed our reaction route. Since 





amination with compound 34 and 30 in hope that the monoalkylated product can be 











Scheme 5.11 Reductive Amination of Compound 30 and Compound 34. 
 
Discouraged by the failures to obtain pure compound 31 via reductive amination, 
we decided to directly synthesize 31 with SN2 reaction of ethyl 4-bromobutyrate. 
However, this N-alkylation reaction appears deceptively simple but it is often unselective 
due to the concomitant overalkylations which give rise to mixtures of primary, secondary, 
and tertiary amines, as well as quaternary ammonium salts. Although, by careful 
adjustment of reaction parameters such as the relative proportions of the reactants, 
reaction temperature, and the use of additives, one can tune conditions accordingly, so 
that the secondary amine becomes predominant. The common protocol includes the most 
conventional conditions utilize an alkali metal carbonate (e.g. K2CO3) in a polar aprotic 
solvent (DMF,DMSO,or MeCN) at room temperature or under heating, depending on the 
nature of the starting materials.
121





was strongly dependent on the number of carbon atoms present in the alkyl bromide; 
longer chain underwent alkylation more efficiently to afford monoalkylation product. 
















Scheme 5.13 Synthesis of Compound 26 (a) NaBH(OAC)3,Methanol, rt, 1h, 16%. (b) 
0.5M HCl, MeOH: H2O (1:0.2), rt, 16 h. (c) 0.1M KOH, MeOH: H2O (1:0.3), rt, 42 h, 
72%. 
 
To synthesize compound 31b, ethyl 4-bromobutyrate was added in portion and 
DMF was added as co-solvent to increase the solubility of K2CO3. These efforts 
contributed to the formation of desired product 31. (Scheme 5.12).
122
 The product was 





performed as shown as scheme 6.21, giving compound 38 in 13 % yield. After acid and 
base hydrolysis, the final compound 26 was obtained (Scheme 5.13).  
 
 
5.5 Materials and Methods 
 
 
5.5.1 Organic Synthesis 
All chemicals were purchased from Sigma-Aldrich or Fisher Scientific unless specified. 
Acetone was dried over Drierite® and then distilled under Ar. CH2Cl2 and DMF were 
distilled over CaH. NMR spectra were recorded on a 300 MHz Bruker spectrometer or 
500 MHz Varian spectrometer. A liquid chromatography Model SIL-10 A (Shimadzu 
Crop.) was used. A LC real time analysis computer integrator was used for retetion time 
mesurements. The UV-Vis detector SPD-20A (Shimadzu Corp.) was used as follows 
detector 1= 260 nm and detector 2= 260 nm. A C-18 reversed phase (7.8 X 150mm) 
column filled with 10 µm (average particle size) was also used. 
 
Compound 27: To a suspension of adenosine (2.0 g, 7.5 mmol) in dry acetone (20 mL) 
was added 36.5 mmol of dry p-TsOH (6.3 g, 4.2 equiv.) in one portion. The mixture was 
stirred under an atmosphere of Ar at room temperature for 2 h. The mixture was stirred 
with 100 mL 0.5M K2CO3 solution for 10 min and then extracted with methylene 
chloride till no spot from the organic extract can be observed on TLC. The organic layer 
was dried over MgSO4 and then filtered. The solvent was evaporated. The product was 
directly used for the next reaction without purification. The white solid was obtained 
(2.14 g, 93%):
1





4.57 (s, 1 H) 5.12 (s, 1 H) 5.19 (s, 1 H) 5.83 (s, 1 H) 5.91 (s, 1 H) 6.52 (s, 1 H) 7.99 (s, 1 
H) 8.33 (s, 1 H). 
 
Compond 28: A solution of 4.88 mmol of 2ʹ,3ʹ-O-isopropylideneadenosine (1.5 g) in 20 
mL of dry dichloromethane was flushed with Ar before 1.71 mL of triethylamine (11.7 
mmol, 2.4 equiv.) and 0.57 mL methanesulfonyl chloride (7.32 mmol, 1.5 equiv.) were 
added.
123 
Solution was stirred at room temperature for 1.5 hr and then 20 mL of saturated 
NaHCO3 solution was added. The layers were separated and the organic layer was 
washed with 20 mL sat. solution of  NaCl. The combined organic layers were dried over 
MgSO4 and the solvent was evaporated. The crude product was purified by silica gel 
chromatography (Ethyl acetate/ Hexane 9:1) to give the mesylate ester (1.8 g, 89 %) as 
colourless foam. The product was directly used for the next reaction without NMR 
identification.  
 
Compound 29: A mixture of 28, (1.70 g, 40 mmol) and sodium azide (2.60 g, 0.04 
mmol, 10 equiv.) was suspended in anhydrous DMF (18 ml). The reaction was heated at 
70 °C for 48 hr.
124
 The mixture was filtered, and evaporated under reduced pressure. 
DMF was removed in vacuo. The residue was purified by silica gel chromatography 
(Ethyl acetate/Hexane 1:9). A Light yellow syrup (818 mg, 60%) was obtained. 
1
H NMR 
(500 MHz, METHANOL-d4) δ ppm 1.33 - 1.41 (m, 3 H) 1.57 - 1.64 (m, 3 H) 3.67 - 3.82 
(m, 2 H) 4.37 (br. s., 1 H) 5.04 (d, J=6 Hz, 1 H) 5.27 (br. s., 1 H) 6.09 - 6.18 (m, 1 H) 






Compound 30: Compound 3 (428 mg) was dissolved in 10 mL methanol; 21.4 mg of 
10% Pd/C was added. The reaction mixture was placed under Ar and then under an 
atmosphere of H2 at 50 psi and the reaction was stirred at r.t for 16 h. The mixture was 
filtered, and evaporated under reduced pressure. The residue was purified by silica gel 
chromatography (15% MeOH in DCM) Compound 30 (282 mg) was obtained in 70% 
yield.
  1
H NMR (300 MHz, CD3OD) δ ppm   1.27 - 1.35 (m, 3 H) 1.49 - 1.57 (m, 3 H) 
2.86 (d, J=6 Hz, 2 H) 4.14 - 4.21 (m, 1 H) 4.96 (d, J=9 Hz, 1 H) 5.38 - 5.45 (m, 1 H) 6.09 
(1 H) 8.11 - 8.17 (m, 1 H) 8.22 (s, 1 H) 
 
Compound 31: NaBH3CN 37 mg (0.58 mmol, 1 equiv.) and AcOH 91.7 μL were added 
to a solution of 180 mg of compound 30 (0.58 mmol, 1 equiv.) and 18 μL of methyl 4-
oxobutanoate (0.18 mmol, 0.3 equiv.) in 1.5 mL MeOH. The reaction mixture was stirred 
at room temperature for 1.5 h. After diluting the reaction with ethyl acetate, the organic 
layer was washed with NaHCO3, dried over MgSO4, and then evaporated under reduced 
pressure.
 
The residue was purified by silica gel chromatography (dichloromethane/ 
methanol 50:3). Compound 5 (28 mg) was obtained in 12% yield.
 1
H NMR (300 MHz, 
CD3OD) δ ppm   1.41 (s, 3 H) 1.58 - 1.64 (m, 3 H) 2.30 (td, J=7, 2 Hz, 2 H) 2.42 - 2.84 
(m, 6 H) 3.65 (s, 3 H) 4.29 - 4.41 (m, 1 H) 5.03 (dd, J= 6, 3 Hz, 1 H) 5.54 (d, J=6, 2 Hz, 
1 H) 6.20 (d, J=2 Hz, 1 H) 8.26 (s, 1 H) 8.29 (s, 1 H) 
 
Ethyl 4-oxobutanoate: A mixture of 0.54 mL of ethyl 4-bromobutyrate, 800 mg of 
pyridine oxide and 673 mg NaHCO3 in 10 mL of toluene was refluxed for 16 hours. 





and then wash with Brine. The crude product was dried on Na2SO4, evaporated under 
reduced pressure and purified by silica gel chromatography. Compound Ethyl 4-
oxobutanoate (50 mg) was obtained in 9.6 % yield.
 1
H NMR (300 MHz, CDCl3) δ ppm
 
1.27 (s, 3 H) 2.63 (s, 2 H) 2.80 (s, 2 H) 4.14 (s, 3 H) 9.82 (s, 1 H) 
 
 
Compound 31a(by reductive amination): NaBH3CN 12.56 mg (0.2 mmol, 1 equiv.) 
and AcOH 13 μL were added to a solution of 60 mg of compound 4 (0.2 mmol, 1 equiv.) 
and Ethyl-4-oxobutanoate (0.06 mmol, 0.3 equiv.) in 1.0 mL MeOH. The reaction 
mixture was stirred at room temperature for 20 min. After diluting the reaction with ethyl 
acetate and sat. NaHCO3 (aq.), the organic layer was washed with NaHCO3, dried over 
MgSO4, and then evaporated under reduced pressure. The residue was purified by silica 
gel chromatography (dichloromethane/methanol 50:6). Compound 31a (8.3 mg) was 
obtained in 10% yield.
 1
H NMR (300 MHz, CDCl3) δ ppm 1.17 - 1.31 (m, 3 H) 1.38 (s, 
3H) 1.62 (3 H) 2.11 (s, 1 H) 2.21 - 2.60 (m, 4 H) 2.98 - 3.54 (m, 3 H) 4.02 - 4.20 (m, 3 H) 
5.10 (br. s., 1 H) 5.29 - 5.54 (m, 1 H) 6.02 - 6.27 (m, 2 H) 7.95 (br. s., 1 H) 8.26 - 8.39 
(m, 1 H) 
 
Compound 31a (by N-alkylation): To a solution of compound 30 in CH3CN: DMF 
(80:1) was addded Ethyl 4-bromobutyrate (114 mg, 0.84 ml) and K2CO3 (100 mg). The 
mixture was heated to 80°C 16 h. After cooling, the mixture was filtered. The filtrate was 
concentrated and purified with column chromatography (DCM/ methanol 100:6) to yield 
31b as a white foam (77 mg, 25%). 
1





H) 1.33 - 1.45 (m, 3 H) 1.62 (s, 3 H) 1.86 (t, J=7 Hz, 2 H) 2.28 - 2.43 (m, 2 H) 2.73 (d, 
J=9 Hz, 1 H) 2.90 - 3.08 (m, 1 H) 4.03 - 4.17 (m, 2 H) 4.43 (d, J=2 Hz, 1 H) 5.10 (dd, 
J=6, 3.03 Hz, 1 H) 5.44 (dd, J=6, 3.19 Hz, 1 H) 6.00 (d, J=3 Hz, 2 H) 7.93 (s, 1 H) 8.32 
(s, 1 H) 
 
Compound 33: To a suspension of compound 2-hydroxyphenethyl alcohol (220 mg, 1.6 
mmol) in DMF (5 ml), K2CO3 (240 mg) was added. To this solution was added benzyl 
bromide (220 µl) and the mixture was stirred at 60°C temperature for 16 h. The residue 
was dissolved in ethyl acetate (100 mL); the solution was washed with H2O and brine, 
dried over MgSO4, and concentrated. The crude product was purified by column 
chromatography (1:19 Hexane: DCM) to yield (2-(o-benzyloxy) phenyl) ethanol (190 
mg, 52%).  
A solution of 2-(o-benzyloxy)phenylethanol (23 mg, 0.10 mmol) and IBX(42 
mg, 0.15 mmol) was stirred at 60°C in THF (3 mL) for 16 h. The reaction was diluted 
with diethyl ether (5 mL) and washed with sodium thiosulfate (5 mL) followed by 
saturated sodium bicarbonate (5 mL). The aqueous layer was back-washed with diethyl 
ether (10 mL). The organic layers were combined, washed with brine, and dried over 
magnesium sulfate. The solvent was evaporated, and the crude was purified with column 
chromatography (30:20 hexanes/DCM) to yield 7 (7.5 mg, 0.33 mmol, 33%). 
1
H NMR 
(500 MHz, CDCl3) δ ppm 3.72 (2 H) 5.11 (s, 2 H) 6.99 (d, J=7 Hz, 2 H) 7.16 - 7.46 (m, 7 






Compound 34: To a stirred solution of 4-nitrophenyl alcohol (0.36 mmol) in acetonitrile 
(3 mL) was added at once 2-iodoxybenzoic acid (IBX, 0.36 mmol). The mixture was 
heated at 80 °C for 2 h and then cooled to rt. The mixture was then filtered through 
Celite® and the solvent was evaporated, giving the expected crude material as a yellow 
oil. The crude was purified with column chromatography (90:10 hexanes: ethyl acetate) 
to yield 34 (20 mg, 34%). 
1
H NMR (300 MHz, CDCl3) δ ppm
 
3.88 (d, J=1 Hz, 2 H) 7.40 
(d, J=8 Hz, 2 H) 8.20 - 8.28 (m, 2 H) 9.83 (t, J=1 Hz, 1 H) 
 
Compound 36:  NaBH3CN 10.2 mg (0.162 mmol, 2 equiv.) and AcOH 4.7μL were 
added to a solution of 33 mg of compound 31 (0.081 mmol) and 7.5 mg (0.33mmol, 1 
equiv.) compound 7 in 1 mL MeOH. The reaction mixture was stirred at room 
temperature for 16 h. After diluting the reaction with ethyl acetate, the organic layer was 
washed with NaHCO3, dried over MgSO4, and then evaporated under reduced pressure.
 
The residue was purified by silica gel chromatography (DCM/methanol 95:5). Compound 
36 (17 mg) was obtained in 34% yield.
 1
H NMR (500 MHz, CDCl3) δ ppm
 
1.16 - 1.43 
(m, 8 H) 1.66 (d, J=11 Hz, 3 H) 2.11 (s, 2 H) 2.36 (t, J=7 Hz, 3 H) 3.16 (br. s., 3 H) 3.65 
(dd, J=13, 5 Hz, 3 H) 4.89 - 5.34 (m, 2 H) 6.23 (br. s., 1 H) 6.94 (br. s., 2 H) 7.43 (br. s., 
6 H) 8.45 - 8.60 (m, 2 H). 
 
Compound 38: NaBH(OAc)3 (35 mg ,0.165 mmol, 1.5equiv.) was added to a solution of 
31b (45 mg, 0.11 mmol) and 34 ( 18 mg, 0.11 mmol, 1 equiv.) in 1 mL DCM. The 
reaction mixture was stirred at room temperature for 30 min. MeOH (0.1 ml) was added 
and the mixture was concentrated.
 





(DCM/methanol 100:3). Compound 38 (10 mg) was obtained in16% yield.
 1
H NMR (300 
MHz, CDCl3) δ ppm 1.25 (t, J=7 Hz, 3 H) 1.38 (s, 3 H) 1.64 (s, 3H) 1.95 (br. s., 2 H) 
2.31 (d, J=6 Hz, 2 H) 2.85 - 3.17 (m, 6 H) 4.12 (q, J=7 Hz, 2 H) 5.11 (br. s., 1 H) 5.38 
(br. s., 1 H) 5.97 - 6.17 (m, 3 H) 7.07 (br. s., 2 H) 7.94 (s, 1 H) 8.01 - 8.11 (m, 2 H) 8.33 
(s, 2 H). 
 
Compound 25: Compound 36 (17 mg) was dissolved in 2 mL methanol; 8.5 mg of 10% 
Pd/C was added. The reaction mixture was placed under an atmosphere of H2 (50 Psi) at 
room temperature for 4 h. The mixture was filtered, and evaporated under a reduced 
pressure. The crude product was directly used for the next reaction without purification. 
Compound 37 (12 mg) was obtained in 81.3% yield. A suspension of compound 37 (12 
mg) in a mixture of 0.2 M methanolic HCl (1ml) and H2O (0.1 ml) was stirred at room 
temperature for 16 h. After adjusting the pH 7.0, the reaction mixture of compound 40 
was directly used for the next reaction without purification. To a suspension of compound 
40 (15 mg), in a mixture of MeOH/H2O (10:1, 1 ml: 0.1 ml), was added 22 mg of KOH 
in one portion. The mixture was stirred at room temperature for 16 h and then 
concentrated under reduced pressure. The residue was purified by HPLC. The flow rate 
was 3 ml/min. The mobile phase consisted of a mixture of MeCN-H2O, (started from 
15:0 V/V till 15: 90 V/V)). The retention time was 1.2 min. 
 
Compound 26: A suspension of compound 38 (8.6 mg) in a mixture of 0.5 M methanolic 
HCl (1mL) and H2O (0.2 mL) was stirred at room temperature for 6 h. After adjusting the 





without purification. To a suspension of compound 41 (8.6 mg) in a mixture of MeOH: 
H2O (1 ml: 0.3 ml) was added 9.6 mg of KOH. The mixture was stirred at room 
temperature for 42 h and then neutralized by acetic acid. The solvent is evaporated at a 
reduced pressure and the residue was purified by silica gel chromatography (DCM / 
methanol 1:1). A yellow foam (5.8 mg, 72%) from 26 was obtained. 
1
H NMR (500 MHz, 
CD3OD) δ ppm  1.79 (br. s., 3 H) 2.18 (d, J=5 Hz, 3 H) 2.59 - 2.74 (m, 2 H) 2.88 - 3.08 
(m, 3 H) 4.07 (d, J=6 Hz, 1 H) 4.14 - 4.33 (m, 2 H) 4.78 (d, J=4 Hz, 1 H) 5.99 (d, J=5 
Hz, 1 H) 7.29 (d, J=8 Hz, 2 H) 7.99 - 8.08 (m, 2 H) 8.21 (s, 1 H) 8.32 (br. s., 1 H) 
 
5.6 Conclusions and Future Studies 
DNA methylation inhibition is an emerging area. Although the first inhibitors were 
discovered in the sixties, there are still a lot of demands to develop more potent and less 
toxic inhibitors, opening a promising road ahead to future therapies. A series of SAH-
derived DNMT inhibitors was designed using a combination of mechanism-based design 
(transition state inhibitor) and structure-based modifications. The inhibition activities will 
be tested in vitro using human DNMT1 assays in future studies. The future perspectives 
lie in developing more similar compounds and elucidating their mechanisms of action in 
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